image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
5574c849fd891f06bb8f91a12403727e84aa9392031efec543b8fc6bb3ad3908.png | simple | <table><tr><td></td><td>Level of guidance</td><td>Nature of guidance</td><td>Health Technology</td></tr><tr><td>Meta regression findings</td><td>Number of sessions not related to outcome</td><td>Better outcomes where guidance provided, and where based on CBT</td><td>No differences between technologies (email, telephone... | <table><tr><td></td><td>Level of guidance</td><td>Nature of guidance</td><td>Health Technology</td></tr><tr><td>Meta regression findings</td><td>Number of sessions not related to outcome</td><td>Better outcomes where guidance provided, and where based on CBT</td><td>No differences between technologies (email, telephone... | <table><tr><td></td><td>Level of guidance</td><td>Nature of guidance</td><td>Health Technology</td></tr><tr><td>Meta synthesis findings</td><td>No relevant findings</td><td>Personal experience characterised by feeling of inability to cope, and disturbances to functioning. Use of lay language/metaphors important</td><td... |
a8c797c35a78c7c81db9adde869f913ce1dd810d74ac142c9865900ea546971b.png | simple | <table><tr><td>Strain</td><td>Acetate</td><td>Formate</td><td>Succinate</td><td>Ethanol</td><td>Carbon Recovery (%)</td></tr><tr><td><i>E. coli </i>C</td><td>0.95 ± 0.08</td><td>1.21 ± 0.03</td><td>0.29 ± 0.03</td><td>0.58 ± 0.05</td><td>100.9 ± 0.41</td></tr><tr><td>CCE14</td><td>0.39 ± 0... | <table><tr><td>Strain</td><td>Acetate</td><td>Formate</td><td>Succinate</td><td>Ethanol</td><td>Carbon Recovery (%)</td></tr></table> | <table><tr><td>E. coli C</td><td>0.95 ± 0.08</td><td>1.21 ± 0.03</td><td>0.29 ± 0.03</td><td>0.58 ± 0.05</td><td>100.9 ± 0.41</td></tr><tr><td>CCE14</td><td>0.39 ± 0.04</td><td>0.67 ± 0.04</td><td>0.28 ± 0.04</td><td>2.08 ± 0.01</td><td>104.5 ± 0.22</td></tr><tr><td>KO11</td><td>0.79 ± 0.04</td><td>1.59 ± 0.06</td><td>... |
de37ac9c50349b580f8841bcefa36fa729821b8e8be9ec279e05c9d71ba7d763.png | complex | <table><tr><td>Variable</td><td></td><td>Range</td></tr><tr><td>Sex, M/F</td><td colspan="2">33/41</td></tr><tr><td>Age, years</td><td>63.5 ± 1.1</td><td>38–78</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>23.0 ± 4.0</td><td>13.7–35.3</td></tr><tr><td>Smoking status, ever/never</td><td colspan="2... | <table><tr><td>Variable</td><td></td><td>Range</td></tr><tr><td>Sex, M/F</td><td colspan="2">33/41</td></tr><tr><td>Age, years</td><td>63.5 ± 1.1</td><td>38–78</td></tr><tr><td>BMI, kg/m2</td><td>23.0 ± 4.0</td><td>13.7–35.3</td></tr><tr><td>Smoking status, ever/never</td><td colspan="2">31/43</td></tr><tr><td>CTD</td>... | <table><tr><td>Surgical lung biopsy, yes/no</td><td colspan="2">33/41</td></tr><tr><td>Corticosteroids/immunosuppressant</td><td colspan="2">23/10</td></tr><tr><td>FVC, % predicted</td><td>81.0 ± 19.1</td><td>38.3–127.0</td></tr><tr><td>DLco, % predicted</td><td>57.1 ± 19.2</td><td>22.6–113.6</td></tr><tr><td>RV, % pre... |
afc364620ea78c10082eb5a1f8333c67e826fb69764da602f743811218ef3293.png | simple | <table><tr><td>Characteristic</td><td>Non-pregnant women (n = 12)</td><td>Pregnant women (n = 12)</td><td><i>P</i></td></tr><tr><td>Age, years</td><td>24.5 (5.6)</td><td>26.2 (8.7)</td><td>0.56</td></tr><tr><td>Weight, kg</td><td>59.9 (1.2)</td><td>61.3 (10.1)</td><td>0.77</td></tr><tr><td>Height, cm</td><td>164.5 (7.6... | <table><tr><td>Characteristic</td><td>Non-pregnant women (n = 12)</td><td>Pregnant women (n = 12)</td><td>P</td></tr></table> | <table><tr><td>Age, years</td><td>24.5 (5.6)</td><td>26.2 (8.7)</td><td>0.56</td></tr><tr><td>Weight, kg</td><td>59.9 (1.2)</td><td>61.3 (10.1)</td><td>0.77</td></tr><tr><td>Height, cm</td><td>164.5 (7.6)</td><td>166 (7.2)</td><td>0.93</td></tr><tr><td>Gestational age, weeks</td><td>–</td><td>32.0 (15.0–40.0)</td><td>–... |
df12d1e444774d83b3ed085a1f48bf400af53fe2877b3d45c8812f8e15dc414d.png | complex | <table><tr><td rowspan="2">Gene</td><td rowspan="2">LTA from strain</td><td rowspan="2">Concentration (μg/mL)</td><td colspan="3">Time</td></tr><tr><td>1 h</td><td>3 h</td><td>24 h</td></tr><tr><td rowspan="4"><i>TNF</i></td><td rowspan="2">233</td><td>1</td><td>4.6 ± <i>0.3</i></td><td><i>68</i> ± <i>1.... | <table><tr><td rowspan="2">Gene</td><td rowspan="2">LTA from strain</td><td rowspan="2">Concentration (μg/mL)</td><td colspan="3">Time</td></tr><tr><td>1 h</td><td>3 h</td><td>24 h</td></tr><tr><td>TNF</td><td>233</td><td>1</td><td>4.6 ± 0.3</td><td>68 ± 1.8</td><td>3.2 ± 0.2</td></tr></table> | <table><tr><td rowspan="2">Gene</td><td rowspan="2">LTA from strain</td><td rowspan="2">Concentration (μg/mL)</td><td colspan="3">Time</td></tr><tr><td>1 h</td><td>3 h</td><td>24 h</td></tr><tr><td rowspan="3">TNF</td><td>233</td><td>10</td><td>5.7 ± 0.0</td><td>110 ± 2.9</td><td>14.1 ± 0.2</td></tr><tr><td rowspan="2"... |
6991298682f0b3327553af06f755e56ac582980b74e1c9f16acf7ff384116c7e.png | complex | <table><tr><td rowspan="2">Environmental variables</td><td colspan="2">Childhood diarrhea</td><td rowspan="2">COR with 95% CI</td><td rowspan="2">AOR with 95% CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td colspan="5">Drinking water source</td></tr><tr><td> Protected</td><td>16</td><td>235</td><td>1</td><td></td><... | <table><tr><td rowspan="2">Environmental variables</td><td colspan="2">Childhood diarrhea</td><td rowspan="2">COR with 95% CI</td><td rowspan="2">AOR with 95% CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td colspan="5">Drinking water source</td></tr><tr><td>Protected</td><td>16</td><td>235</td><td>1</td><td></td></... | <table><tr><td rowspan="2">Environmental variables</td><td colspan="2">Childhood diarrhea</td><td rowspan="2">COR with 95% CI</td><td rowspan="2">AOR with 95% CI</td></tr><tr><td>Yes</td><td>No</td></tr><tr><td>Pouring</td><td>182</td><td>502</td><td>1</td><td></td></tr><tr><td>Dipping</td><td>2</td><td>18</td><td>0.30... |
2b1dcab4b07e7cd5373e93054c36f354f7d49fb41997975b3d6da84d5a8fec04.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Survival</td><td colspan="2">Body Weight</td><td rowspan="2">Ascites Fluid (mL) on the 10th Day</td><td rowspan="2">Tumour Cells <sup>b</sup></td><td rowspan="2">Neutrophil <sup>c</sup></td></tr><tr><td>Day 1</td><td>Day 11</td></tr><tr><td>Control EAC</td><td>3/10</td><t... | <table><tr><td rowspan="2"></td><td rowspan="2">Survival</td><td colspan="2">Body Weight</td><td rowspan="2">Ascites Fluid (mL) on the 10th Day</td><td rowspan="2">Tumour Cells b</td><td rowspan="2">Neutrophil c</td></tr><tr><td>Day 1</td><td>Day 11</td></tr><tr><td>Control EAC</td><td>3/10</td><td>23.1 ± 0.6</td><td>2... | <table><tr><td rowspan="2"></td><td rowspan="2">Survival</td><td colspan="2">Body Weight</td><td rowspan="2">Ascites Fluid (mL) on the 10th Day</td><td rowspan="2">Tumour Cells b</td><td rowspan="2">Neutrophil c</td></tr><tr><td>Day 1</td><td>Day 11</td></tr><tr><td>)</td><td></td><td>± 0.5</td><td>5</td><td>0.6</td><t... |
4a20bebb36391381a5c0d7ba59f832dbc6c7e066d2060a03b743aca29e372105.png | complex | <table><tr><td rowspan="2">Locus</td><td rowspan="2">Alleles</td><td colspan="2">Parasitaemia</td><td rowspan="2"><i>χ</i>2 significance</td></tr><tr><td>Low (< 1,000/μl)</td><td>Moderate to high (≥1,000/μl)</td></tr><tr><td rowspan="2"><i>Pfcrt </i>76</td><td>Mutant</td><td>8</td><td>31</td><td... | <table><tr><td rowspan="2">Locus</td><td rowspan="2">Alleles</td><td colspan="2">Parasitaemia</td><td rowspan="2">χ2 significance</td></tr><tr><td>Low (< 1,000/μl)</td><td>Moderate to high (≥1,000/μl)</td></tr><tr><td rowspan="2">Pfcrt 76</td><td>Mutant</td><td>8</td><td>31</td><td><0.001</td></tr><tr><td>Wild</td><td>... | <table><tr><td rowspan="2">Pfcrt 356</td><td>Mutant</td><td>1</td><td>17</td><td><0.001*</td></tr><tr><td>Wild</td><td>30</td><td>27</td><td></td></tr><tr><td rowspan="2">Pfcrt 371</td><td>Mutant</td><td>22</td><td>36</td><td>0.409</td></tr><tr><td>Wild</td><td>9</td><td>8</td><td></td></tr><tr><td rowspan="2">Pfmdr1 -... |
58dd3b85d8dbcc474734599897b37067836b04df9d7b8eba335fa95f0fb3b744.png | simple | <table><tr><td>Data subset</td><td>Accuracy</td><td>Accuracy (%)</td><td>False positives</td><td>False negatives</td><td>MCC score</td></tr><tr><td>All samples</td><td>2290 of 2315</td><td>98.92</td><td>2 of 2159</td><td>23 of 156</td><td>0.91</td></tr><tr><td>EC origin cells</td><td>558 of 564</td><td>98.94</td><td>0 ... | <table><tr><td>Data subset</td><td>Accuracy</td><td>Accuracy (%)</td><td>False positives</td><td>False negatives</td></tr><tr><td>All samples</td><td>2290 of 2315</td><td>98.92</td><td>2 of 2159</td><td>23 of 156</td></tr><tr><td>EC origin cells</td><td>558 of 564</td><td>98.94</td><td>0 of 535</td><td>6 of 29</td></tr... | <table><tr><td>MCC score</td></tr><tr><td>0.91</td></tr><tr><td>0.89</td></tr><tr><td>0.93</td></tr><tr><td>0.9</td></tr><tr><td>0.81</td></tr></table> |
55114ca33ce625c42df1feedd958a051c4188de2ce34ecc1c8568fc491593056.png | complex | <table><tr><td>Primary antibody</td><td>Host</td><td>Manufacturer; catalog no.; dilution</td><td>Secondary antibody</td></tr><tr><td colspan="4">Enhanced chemiluminescent (ECL) detection</td></tr><tr><td> Anti-phospho-S6 (P-S6) Ser235/236</td><td>Rabbit</td><td>Cell Signaling Technology, Beverly, MA; #4858; 1:500 in 5 ... | <table><tr><td>Primary antibody</td><td>Host</td><td>Manufacturer; catalog no.; dilution</td><td>Secondary antibody</td></tr><tr><td colspan="4">Enhanced chemiluminescent (ECL) detection</td></tr><tr><td>Anti-phospho-S6 (P-S6) Ser235/236</td><td>Rabbit</td><td>Cell Signaling Technology, Beverly, MA; #4858; 1:500 in 5 %... | <table><tr><td colspan="4">nofluorescence</td></tr><tr><td>Anti-phospho-S6 (P-S6) Ser235/236</td><td>Rabbit</td><td>Cell Signaling Technology, Beverly, MA; #4858; 1:200 in 1 % donkey serum in PBS-Tc</td><td rowspan="4">Anti-rabbit IgG Alexa Fluor 488; Life Technologies, Carlsbad, CA; A-21206; 1:500 in 1 % donkey serum ... |
ed0c88b2ac5855482f691b5865740cf08359b8bceffd60218bd7bc789c9e9d85.png | simple | <table><tr><td>Type of study</td><td>Complete articles</td><td>Abstracts</td><td>Total</td><td>No. of Patients</td></tr><tr><td>All studies</td><td>8</td><td>2</td><td>10</td><td>249</td></tr><tr><td>Prospective</td><td>5</td><td>1</td><td>6</td><td>106</td></tr><tr><td>Retrospective</td><td>3</td><td>1</td><td>4</td><... | <table><tr><td>Type of study</td><td>Complete articles</td><td>Abstracts</td><td>Total</td><td>No. of Patients</td></tr><tr><td>All studies</td><td>8</td><td>2</td><td>10</td><td>249</td></tr><tr><td>Prospective</td><td>5</td><td>1</td><td>6</td><td>106</td></tr><tr><td>Retrospective</td><td>3</td><td>1</td><td>4</td><... | <table><tr><td>Type of study</td><td>Complete articles</td><td>Abstracts</td><td>Total</td><td>No. of Patients</td></tr><tr><td>De novo use of RTX</td><td>6</td><td>1</td><td>7</td><td>179</td></tr><tr><td>RTX used for refractory AMR</td><td>2</td><td>1</td><td>3</td><td>70</td></tr><tr><td>Pediatric</td><td>1</td><td>... |
a7a1ec92fa6c6532a6e4c1c77f1ad8fdb972debc3ffb07e26970fe7fea65b418.png | simple | <table><tr><td>Strain</td><td>Maximum specific growth rate (h<sup>-1</sup>)</td></tr><tr><td>HZ848</td><td>0.15 ± 0.01</td></tr><tr><td>HZ848-<i>siz1Δ</i></td><td>0.19 ± 0.00</td></tr><tr><td>W303a</td><td>0.19 ± 0.01</td></tr><tr><td>W303a-<i>siz1Δ</i></td><td>0.30 ± 0.01</td></tr></table... | <table><tr><td>Strain</td><td>Maximum specific growth rate (h-1)</td></tr><tr><td>HZ848</td><td>0.15 ± 0.01</td></tr></table> | <table><tr><td>Strain</td><td>Maximum specific growth rate (h-1)</td></tr><tr><td>HZ848-siz1Δ</td><td>0.19 ± 0.00</td></tr><tr><td>W303a</td><td>0.19 ± 0.01</td></tr><tr><td>W303a-siz1Δ</td><td>0.30 ± 0.01</td></tr></table> |
6c5218046d107a0f51105d41b0aa795682caab8387462a1de007439d584ed961.png | simple | <table><tr><td>Sample</td><td>Size (nm)</td><td>Zeta Potential (mV)</td><td>PdI</td><td>Encapsulation Efficiency (%)</td></tr><tr><td>CNPs</td><td>159.6 ± 2.2</td><td>24.50 ± 3.64</td><td>0.272 ± 0.01</td><td>-</td></tr><tr><td>CNPs/BJ 5</td><td>179.3 ± 9.4 **</td><td>23.03 ± 3.09</td><td>0.188... | <table><tr><td>Sample</td><td>Size (nm)</td><td>Zeta Potential (mV)</td><td>PdI</td><td>Encapsulation Efficiency (%)</td></tr><tr><td>CNPs</td><td>159.6 ± 2.2</td><td>24.50 ± 3.64</td><td>0.272 ± 0.01</td><td>-</td></tr><tr><td>CNPs/BJ 5</td><td>179.3 ± 9.4 **</td><td>23.03 ± 3.09</td><td>0.188 ± 0.08</td><td>76.7</td>... | <table><tr><td>Sample</td><td>Size (nm)</td><td>Zeta Potential (mV)</td><td>PdI</td><td>Encapsulation Efficiency (%)</td></tr><tr><td>CNPs/BJ 15</td><td>187.3 ± 7.5 ***</td><td>31.40 ± 3.86</td><td>0.185 ± 0.07</td><td>74.0</td></tr><tr><td>CNPs/BE 5</td><td>189.4 ± 1.0 ***</td><td>20.71 ± 2.93</td><td>0.305 ± 0.05</td... |
738af90e1e18e02df90dcdc241cd4103171418a7d117ee8f9d9e19c0a7da317c.png | simple | <table><tr><td></td><td>Initial polysomnography</td><td>Titration studya</td><td>At therapeutic pressureb</td></tr><tr><td>Time in Bed (min)</td><td>355</td><td>360</td><td>84.5</td></tr><tr><td>Total Sleep Time (min)</td><td>277.5</td><td>253</td><td>83</td></tr><tr><td>Stage N1 (%/min)</td><td>3.6/10</td><td>4/10</td... | <table><tr><td></td><td>Initial polysomnography</td><td>Titration studya</td><td>At therapeutic pressureb</td></tr></table> | <table><tr><td>Time in Bed (min)</td><td>355</td><td>360</td><td>84.5</td></tr><tr><td>Total Sleep Time (min)</td><td>277.5</td><td>253</td><td>83</td></tr><tr><td>Stage N1 (%/min)</td><td>3.6/10</td><td>4/10</td><td>35/29</td></tr><tr><td>Stage N2 (%/minutes)</td><td>29.2/81</td><td>25.1/64</td><td>15/12</td></tr><tr>... |
60cbad6cac08edcb788da8206f477808a74fb8667cff7257f51c694aed3d55c5.png | simple | <table><tr><td></td><td>Function</td><td><i>cis</i> element</td><td>Sequence</td><td>Position</td><td>TF family</td></tr><tr><td>1</td><td>Defense against insect herbivory</td><td>AtMYC2 BS in RD22</td><td>CACATG</td><td>(1578-1583)</td><td>BHLH</td></tr><tr><td>2</td><td>Development</td><td>Bellringer/Replumless /Penn... | <table><tr><td></td><td>Function</td><td>cis element</td><td>Sequence</td><td>Position</td><td>TF family</td></tr><tr><td>1</td><td>Defense against insect herbivory</td><td>AtMYC2 BS in RD22</td><td>CACATG</td><td>(1578-1583)</td><td>BHLH</td></tr><tr><td>2</td><td>Development</td><td>Bellringer/Replumless /Pennywise</... | <table><tr><td></td><td>Function</td><td>cis element</td><td>Sequence</td><td>Position</td></tr><tr><td>15</td><td>Light response</td><td>GATA promoter motif [LRE]</td><td>AGATAA</td><td>(287-292) (96-101)</td></tr><tr><td>16</td><td>Light response</td><td>GATA promoter motif [LRE]</td><td>TGATAA</td><td>(2308-2313)</t... |
3d8fca2d982726a037a7fea9d29d0d91b40620af711bd441f29a097e5e1a580e.png | complex | <table><tr><td>Variable</td><td>No. of subjects<sup>a</sup></td><td>HEV antibody prevalence (%)</td><td>Odds ratio (95% CI)</td><td><i>P</i></td></tr><tr><td colspan="4">Age (years)</td><td><0.008<sup>b</sup></td></tr><tr><td>5-10</td><td>66</td><td>9.1</td><td>1.00</td><td></td></tr><tr><td>11-20</td><td>107</td><t... | <table><tr><td>Variable</td><td>No. of subjectsa</td><td>HEV antibody prevalence (%)</td><td>Odds ratio (95% CI)</td><td>P</td></tr><tr><td colspan="4">Age (years)</td><td><0.008b</td></tr><tr><td>5-10</td><td>66</td><td>9.1</td><td>1.00</td><td></td></tr><tr><td>11-20</td><td>107</td><td>4.7</td><td>0.49 (0.11-2.03)</... | <table><tr><td>Variable</td><td>No. of subjectsa</td><td>HEV antibody prevalence (%)</td><td>Odds ratio (95% CI)</td><td>P</td></tr><tr><td>No</td><td>337</td><td>13.3</td><td>1.00</td><td>0.631</td></tr><tr><td>Yes</td><td>52</td><td>9.8</td><td>0.71 (0.21-1.91)</td><td></td></tr><tr><td colspan="4">Education of house... |
24d1a44055003f63cb13441e7d2e28de4d10cfbeb4a126f1f0c8923a9b484887.png | simple | <table><tr><td>Region</td><td>States in region</td><td>Selected states, medical colleges, and cities</td></tr><tr><td>North</td><td>Delhi, Rajasthan, Jammu and Kashmir, Himachal Pradesh, Punjab, Haryana, Uttarakhand and Chandigarh</td><td>NCT of Delhi (Lady Harding Medical College, Delhi), Rajasthan (NIMS Medical Colle... | <table><tr><td>Region</td><td>States in region</td><td>Selected states, medical colleges, and cities</td></tr><tr><td>North</td><td>Delhi, Rajasthan, Jammu and Kashmir, Himachal Pradesh, Punjab, Haryana, Uttarakhand and Chandigarh</td><td>NCT of Delhi (Lady Harding Medical College, Delhi), Rajasthan (NIMS Medical Colle... | <table><tr><td>Region</td><td>States in region</td><td>Selected states, medical colleges, and cities</td></tr><tr><td>ral</td><td>Uttar Pradesh, Chhattisgarh, and Madhya Pradesh</td><td>al Sciences and Research, Lucknow), Madhya Pradesh (G.R. Medical College, Gwalior)</td></tr></table> |
42bb3d48db603ef502e86169b7f0dab68a79a1b03d1bcbab6c1d1397a93a21dd.png | simple | <table><tr><td>Risk Factor Goals</td><td> </td></tr><tr><td>Blood Pressure</td><td>BP 130/80 mmHg</td></tr><tr><td>Diabetes Mellitus</td><td>Fasting or pre-prandial glucose of 4-6, or a HbA1C < 6.5%</td></tr><tr><td>Lipids</td><td>Total cholesterol less than 4 mmol/l or an LDL < 2.0 mmol/l</td></tr><tr><td>Smokin... | <table><tr><td>Risk Factor Goals</td><td></td></tr><tr><td>Blood Pressure</td><td>BP 130/80 mmHg</td></tr><tr><td>Diabetes Mellitus</td><td>Fasting or pre-prandial glucose of 4-6, or a HbA1C < 6.5%</td></tr><tr><td>Lipids</td><td>Total cholesterol less than 4 mmol/l or an LDL < 2.0 mmol/l</td></tr></table> | <table><tr><td>Smoking</td><td>Smoking cessation</td></tr><tr><td>Weight</td><td>BMI < 25</td></tr></table> |
a58ed84831fbd18d7d29a5a38dcc127ab0f19cdc0f7237b11dc780ae47b4b845.png | complex | <table><tr><td>Strain</td><td>SC 5314</td><td><i>opt1</i>Δ</td><td><i>opt2</i>Δ <i>opt3</i>Δ</td><td><i>opt4</i>Δ</td><td><i>opt5</i>Δ</td><td><i>opt1–opt5</i>Δ</td><td><i>ptr2</i>Δ <i>ptr22</i>Δ</td><td><i>opt1–opt5</i>Δ <i>ptr2</i>Δ <i>ptr22</i>Δ</td>... | <table><tr><td>Strain</td><td>SC 5314</td><td>opt1Δ</td><td>opt2Δ opt3Δ</td><td>opt4Δ</td><td>opt5Δ</td><td>opt1–opt5Δ</td><td>ptr2Δ ptr22Δ</td><td>opt1–opt5Δ ptr2Δ ptr22Δ</td></tr><tr><td>Peptide</td><td colspan="6">MIC (μg mL-1)</td><td colspan="2"></td></tr></table> | <table><tr><td>Strain</td><td>SC 5314</td><td>opt1Δ</td><td>opt2Δ opt3Δ</td><td>opt4Δ</td><td>opt5Δ</td><td>opt1–opt5Δ</td><td>ptr2Δ ptr22Δ</td><td>opt1–opt5Δ ptr2Δ ptr22Δ</td></tr><tr><td>F2</td><td>0.25</td><td>0.25</td><td>0.25</td><td>0.25</td><td>0.25</td><td>0.5</td><td>>128</td><td>>128</td></tr><tr><td>F3</td><... |
7f03e2189e80e1bf088cdccd48a708a3fc1d0d81b90263978a722112cdba9939.png | complex | <table><tr><td rowspan="2">Regimens</td><td rowspan="2">n (<i>n</i> = 612)</td><td colspan="2">CINV [n (%)]</td></tr><tr><td>Grade 0-II (<i>n</i> = 339)</td><td>Grade III-IV (<i>n</i> = 273)</td></tr><tr><td>CAF</td><td>59</td><td>36 (61.0)</td><td>23 (39.0)</td></tr><tr><td>CEF</td><td>107</td><td>59 (55.1)</td><td>48... | <table><tr><td rowspan="2">Regimens</td><td rowspan="2">n (n = 612)</td><td colspan="2">CINV [n (%)]</td></tr><tr><td>Grade 0-II (n = 339)</td><td>Grade III-IV (n = 273)</td></tr><tr><td>CAF</td><td>59</td><td>36 (61.0)</td><td>23 (39.0)</td></tr><tr><td>CEF</td><td>107</td><td>59 (55.1)</td><td>48 (44.9)</td></tr><tr>... | <table><tr><td>E</td><td></td><td>74 (60.7)</td><td> (39.3)</td></tr><tr><td>TAC</td><td>61</td><td>40 (65.6)</td><td>21 (34.4)</td></tr><tr><td>TA</td><td>51</td><td>24 (47.1)</td><td>27 (52.9)</td></tr><tr><td>AC</td><td>40</td><td>21 (52.5)</td><td>19 (47.5)</td></tr><tr><td>EC</td><td>115</td><td>56 (48.7)</td><td>... |
32313a8f1a531abbec902f3c7da41ab23a54efb7d047f98a5adff3d40e386a33.png | simple | <table><tr><td>Compositional Category</td><td>Features in Chloroplast</td></tr><tr><td>CP genome length (nt)</td><td>155,989</td></tr><tr><td>LSC length (nt)</td><td>85,912</td></tr><tr><td>SSC length (nt)</td><td>17,517</td></tr><tr><td>IR length (Ira/b) (nt)</td><td>52,560</td></tr><tr><td>AT/GC contents (%)</td><td>... | <table><tr><td>Compositional Category</td></tr><tr><td>CP genome length (nt)</td></tr><tr><td>LSC length (nt)</td></tr><tr><td>SSC length (nt)</td></tr><tr><td>IR length (Ira/b) (nt)</td></tr><tr><td>AT/GC contents (%)</td></tr><tr><td>No. of total/unique genes</td></tr><tr><td>Genic occupancy (nt)</td></tr><tr><td>Int... | <table><tr><td>Features in Chloroplast</td></tr><tr><td>155,989</td></tr><tr><td>85,912</td></tr><tr><td>17,517</td></tr><tr><td>52,560</td></tr><tr><td>62.34/37.66</td></tr><tr><td>129/111</td></tr><tr><td>88,065</td></tr><tr><td>67,924</td></tr><tr><td>78</td></tr><tr><td>29</td></tr><tr><td>4</td></tr><tr><td>16</td... |
ac2fa693db5668b828ea44972262bb3cb745c047d462f4b154dc4aa56d85bdf3.png | simple | <table><tr><td>Data Set</td><td>Score Used</td><td>Positive</td><td>Negative</td><td>Close to Zero</td><td>Total Tested</td></tr><tr><td>Ma–Mu</td><td>Sum of signs of translation shift scores</td><td>597</td><td>569</td><td>58</td><td>16,942</td></tr><tr><td>Fa–Fu</td><td>Sum of signs of translation shift s... | <table><tr><td>Data Set</td><td>Score Used</td></tr><tr><td>Ma–Mu</td><td>Sum of signs of translation shift scores</td></tr><tr><td>Fa–Fu</td><td>Sum of signs of translation shift scores</td></tr><tr><td>Fa–Fu</td><td>Count of CpG</td></tr></table> | <table><tr><td>Positive</td><td>Negative</td><td>Close to Zero</td><td>Total Tested</td></tr><tr><td>597</td><td>569</td><td>58</td><td>16,942</td></tr><tr><td>48</td><td>60</td><td>5</td><td>15,045</td></tr><tr><td>84</td><td>85</td><td>15</td><td>12,491</td></tr></table> |
debaf094842b117771787ab6cba7457f84ebc7551b92e1027d9c54f47710a8ff.png | simple | <table><tr><td></td><td>no DM</td><td>DM</td><td><i>P</i></td></tr><tr><td>XMP</td><td>13 585 (8 386, 29 579)</td><td>62 101 (14 261, 158 938)</td><td>5.0E-7*</td></tr><tr><td>VMA</td><td>173 153 (107 165, 279 690)</td><td>104 186 (67 902, 164 683)</td><td>1.5E-6*</td></tr><tr><td>Glucose</td><td>2 935 (1 046, 5 294)</... | <table><tr><td></td><td>no DM</td><td>DM</td><td>P</td></tr><tr><td>XMP</td><td>13 585 (8 386, 29 579)</td><td>62 101 (14 261, 158 938)</td><td>5.0E-7*</td></tr><tr><td>VMA</td><td>173 153 (107 165, 279 690)</td><td>104 186 (67 902, 164 683)</td><td>1.5E-6*</td></tr><tr><td>Glucose</td><td>2 935 (1 046, 5 294)</td><td>... | <table><tr><td></td><td>no DM</td><td>DM</td><td>P</td></tr><tr><td>PEP</td><td>312 003 (189 719, 522 172)</td><td>462 016 (257 705, 925 860)</td><td>1.3E-3</td></tr><tr><td>ribose-5-P-rib</td><td>144 443 (104 797, 208 719)</td><td>180 078 (116 088, 322 799)</td><td>8.7E-3</td></tr></table> |
c5bbe42885c2f7bb30627d4bc71bd1369a1d1a16fa67dc520033d338efbb5fc1.png | simple | <table><tr><td>Participant</td><td>Outcome measure</td><td>Instrument</td><td>baseline</td><td>3 months</td><td>6 months</td></tr><tr><td>Patient</td><td>Self-perceived performance in daily activities<sup>a</sup></td><td>Canadian Occupational Performance Measure (COPM; performance rating) [25]</td><td><i>√</i></t... | <table><tr><td>Participant</td><td>Outcome measure</td><td>Instrument</td><td>baseline</td><td>3 months</td><td>6 months</td></tr><tr><td>Patient</td><td>Self-perceived performance in daily activitiesa</td><td>Canadian Occupational Performance Measure (COPM; performance rating) [25]</td><td>√</td><td>√</td><td>√</td></... | <table><tr><td></td><td>Proactive coping</td><td>Utrecht Proactive Coping Competence scale (UPCC) [40]</td><td>√</td><td>√</td><td>√</td></tr><tr><td></td><td>Resource utilization</td><td>Resource utilization questionnaire: patient and caregiver version</td><td>√</td><td>√</td><td>√</td></tr></table> |
a4cc5d8dd1107397cb9b3b5e6d86e03451b33badcc0ecf2e60f23303ce311d2f.png | simple | <table><tr><td>Birth defects</td><td>Number of cases</td><td>Birth prevalence/10,000 and 95%CI</td></tr><tr><td>Anencephaly</td><td>0</td><td>0 (0–6.3)</td></tr><tr><td>Spin bifida</td><td>1</td><td>1.7 (0–9.5)</td></tr><tr><td>Encephalocele</td><td>0</td><td>0 (0–6.3)</td></tr><tr><td>Microcephaly</t... | <table><tr><td>Birth defects</td></tr><tr><td>Anencephaly</td></tr><tr><td>Spin bifida</td></tr><tr><td>Encephalocele</td></tr><tr><td>Microcephaly</td></tr><tr><td>Arhinencephaly/holoprosencephaly</td></tr><tr><td>Hydrocephaly</td></tr><tr><td>Buphtalmos</td></tr><tr><td>Congenital cataract</td></tr><tr><td>Anotia/mic... | <table><tr><td>Number of cases</td><td>Birth prevalence/10,000 and 95%CI</td></tr><tr><td>0</td><td>0 (0–6.3)</td></tr><tr><td>1</td><td>1.7 (0–9.5)</td></tr><tr><td>0</td><td>0 (0–6.3)</td></tr><tr><td>1</td><td>1.7 (0–9.5)</td></tr><tr><td>4</td><td>6.8 (1.9–17.4)</td></tr><tr><td>4</td><td>6.8 (1.9–17.4)</td></tr><t... |
33f123bb47ff71273479911248f9f17ed8eca24cd556f8d3dfa1505f33a1cdcc.png | simple | <table><tr><td></td><td>T2DM</td><td>T2DM + MC</td><td>Control</td></tr><tr><td>Gender (M/F)</td><td>73/39</td><td>77/41</td><td>37/23</td></tr><tr><td>Age (years)</td><td>75.1 ± 2.1</td><td>76.1 ± 3.1</td><td>73.3 ± 6.2</td></tr><tr><td>Duration (years)</td><td>15.2 ± 4.3</td><td>16.8 ± 3.4</t... | <table><tr><td></td><td>T2DM</td><td>T2DM + MC</td><td>Control</td></tr><tr><td>Gender (M/F)</td><td>73/39</td><td>77/41</td><td>37/23</td></tr><tr><td>Age (years)</td><td>75.1 ± 2.1</td><td>76.1 ± 3.1</td><td>73.3 ± 6.2</td></tr><tr><td>Duration (years)</td><td>15.2 ± 4.3</td><td>16.8 ± 3.4</td><td>NA</td></tr><tr><td... | <table><tr><td></td><td>T2DM</td><td>T2DM + MC</td><td>Control</td></tr><tr><td>CHD, n</td><td>37★</td><td>55★●</td><td>16</td></tr><tr><td>1</td><td>64</td><td>45</td><td>None</td></tr><tr><td>2</td><td>33</td><td>47</td><td>None</td></tr><tr><td>3</td><td>13</td><td>28●</td><td>None</td></tr></table> |
1c2ac7248e4f39c53b5439817ee5e5f42a4884eece93e6895d736b471a64ad27.png | simple | <table><tr><td>User</td><td>Dice</td><td>ASSD(mm)</td><td><i>κ</i></td></tr><tr><td>1</td><td>0.81±0.02</td><td>2.73±0.62</td><td>0.931</td></tr><tr><td>2</td><td>0.82±0.03</td><td>2.57±0.60</td><td>0.936</td></tr><tr><td>3</td><td>0.81±0.03</td><td>2.75±0.61</td><td>0.949</td></tr><t... | <table><tr><td>User</td><td>Dice</td></tr><tr><td>1</td><td>0.81±0.02</td></tr><tr><td>2</td><td>0.82±0.03</td></tr><tr><td>3</td><td>0.81±0.03</td></tr><tr><td>4</td><td>0.80±0.03</td></tr><tr><td>5</td><td>0.82±0.02</td></tr><tr><td>6</td><td>0.82±0.02</td></tr><tr><td>7</td><td>0.82±0.02</td></tr><tr><td>8</td><td>0... | <table><tr><td>ASSD(mm)</td><td>κ</td></tr><tr><td>2.73±0.62</td><td>0.931</td></tr><tr><td>2.57±0.60</td><td>0.936</td></tr><tr><td>2.75±0.61</td><td>0.949</td></tr><tr><td>2.81±0.73</td><td>0.941</td></tr><tr><td>2.58±0.61</td><td>0.948</td></tr><tr><td>2.63±0.61</td><td>0.945</td></tr><tr><td>2.61±0.74</td><td>0.941... |
638ce509484805367dc1aeabdc44c73ec0b99fa05b2374a9c9f32d6cf28dab15.png | complex | <table><tr><td rowspan="2">Service area</td><td colspan="3">Number of MNH providers observed</td><td colspan="3">Number of provider-client interactions observed</td><td colspan="3">Intraclass Correlation Coefficient (ICC)</td></tr><tr><td>Total</td><td>Inter-vention group</td><td>Com-parison group</td><td>Total</td><td... | <table><tr><td rowspan="2">Service area</td><td colspan="3">Number of MNH providers observed</td><td colspan="3">Number of provider-client interactions observed</td><td colspan="3">Intraclass Correlation Coefficient (ICC)</td></tr><tr><td>Total</td><td>Inter-vention group</td><td>Com-parison group</td><td>Total</td><td... | <table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Provider</td><td>0.658</td><td>0.574</td></tr></table> |
bc92e9b8771a43500f2f3ae057f1dbaea4bab5ac09d81013dc4d6602318b1d48.png | complex | <table><tr><td></td><td colspan="3">Females</td><td colspan="3">Males</td></tr><tr><td>Gene</td><td>Coefficient estimate</td><td>Standard error</td><td><i>P</i>-value</td><td>Coefficient estimate</td><td>Standard error</td><td><i>P</i>-value</td></tr><tr><td><i>AQP9</i></td><td>0.411</td><td>0.133</td><td>0.003**</td><... | <table><tr><td></td><td colspan="2">Females</td></tr><tr><td>Gene</td><td>Coefficient estimate</td><td>Standard error</td></tr><tr><td>AQP9</td><td>0.411</td><td>0.133</td></tr><tr><td>AS3MT</td><td>−0.115</td><td>0.074</td></tr><tr><td>GSTM1</td><td>0.107</td><td>0.435</td></tr><tr><td>SLC39A2</td><td>−0.105</td><td>0... | <table><tr><td>Females</td><td colspan="3">Males</td></tr><tr><td>P-value</td><td>Coefficient estimate</td><td>Standard error</td><td>P-value</td></tr><tr><td>0.003**</td><td>0.028</td><td>0.156</td><td>0.857</td></tr><tr><td>0.126</td><td>0.058</td><td>0.082</td><td>0.483</td></tr><tr><td>0.806</td><td>−0.279</td><td>... |
3a7b7d5abfe5a3a52458cc75a4aa0b8e2dd627e2dee87a63bd6434fd62e3c5d4.png | simple | <table><tr><td>Anti-VLY scFv</td><td>Expression level, % of total cell protein</td><td>Oligomeric state</td><td>Activity (%) after 12 months storage at 4°C</td></tr><tr><td>scFv 9B4 (VL-VH)</td><td>20-30</td><td>monomeric</td><td>100</td></tr><tr><td>scFv 9B4 (VH-VL)</td><td>20-30</td><td>monomeric</td><td>100</td... | <table><tr><td>Anti-VLY scFv</td><td>Expression level, % of total cell protein</td><td>Oligomeric state</td><td>Activity (%) after 12 months storage at 4°C</td></tr><tr><td>scFv 9B4 (VL-VH)</td><td>20-30</td><td>monomeric</td><td>100</td></tr><tr><td>scFv 9B4 (VH-VL)</td><td>20-30</td><td>monomeric</td><td>100</td></tr... | <table><tr><td>scFv 23A2 (VH-VL)</td><td>20-30</td><td>monomeric</td><td>75</td></tr></table> |
03b5d3a0fbca9312ebcad5b365154cb854c5c4296b1a352e28238208dfaf1574.png | simple | <table><tr><td></td><td>Plasma membrane number / %</td><td>Intracellular number / %</td><td>Total immunogold number / %</td></tr><tr><td>P7</td></tr><tr><td><i>Dendritic spines</i></td><td>88/7,6</td><td>107/9,2</td><td>195/16,9</td></tr><tr><td><i>Dendritic shafts</i></td><td>415/35,9</td><td>521/45</td><td>936/80,9</... | <table><tr><td></td><td>Plasma membrane number / %</td><td>Intracellular number / %</td><td>Total immunogold number / %</td></tr><tr><td>P7</td><td colspan="3"></td></tr><tr><td>Dendritic spines</td><td>88/7,6</td><td>107/9,2</td><td>195/16,9</td></tr><tr><td>Dendritic shafts</td><td>415/35,9</td><td>521/45</td><td>936... | <table><tr><td></td><td>Plasma membrane number / %</td><td>Intracellular number / %</td><td>Total immunogold number / %</td></tr><tr><td>Dendritic spines</td><td>697/32,3</td><td>213/9,9</td><td>910/42,1</td></tr><tr><td>Dendritic shafts</td><td>602/27,9</td><td>422/19,6</td><td>1024/47,4</td></tr><tr><td>Axon terminal... |
7e23d3b54b3c92f98d1bebac38e16fb42a561e247f2ffc0a1477785387ba249e.png | simple | <table><tr><td>Characteristics</td><td>% (SE)</td></tr><tr><td>Age, y<sup>b</sup></td><td>45.2 ± 0.2</td></tr><tr><td> < 65</td><td>86.2 (0.6)</td></tr><tr><td> ≥ 65</td><td>13.8 (0.6)</td></tr><tr><td>Sex</td><td> </td></tr><tr><td> Male</td><td>49.5 (0.5)</td></tr><tr><td> Female</td><td>50.5 (0.5)</td>... | <table><tr><td>Characteristics</td><td>% (SE)</td></tr><tr><td>Age, yb</td><td>45.2 ± 0.2</td></tr><tr><td>< 65</td><td>86.2 (0.6)</td></tr><tr><td>≥ 65</td><td>13.8 (0.6)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>49.5 (0.5)</td></tr><tr><td>Female</td><td>50.5 (0.5)</td></tr><tr><td>BMI, kg/m2</td><t... | <table><tr><td>≥ 25</td><td>31.1 (0.9)</td></tr><tr><td>Smoking exposure</td><td></td></tr><tr><td>Never</td><td>74.3 (0.7)</td></tr><tr><td>Former or current</td><td>25.7 (0.7)</td></tr><tr><td>Alcohol drinking, g/day</td><td></td></tr><tr><td>< 30</td><td>90.1 (0.6)</td></tr><tr><td>≥ 30</td><td>9.9 (0.6)</td></tr><t... |
cb42feb568ca5b0f7eca59fd9ca90eb74143bba53617a721cf321750196361dc.png | simple | <table><tr><td>Comparison</td><td>Keyword</td><td>Gene Set</td><td>Gene Set Description</td><td>Size</td><td>p-valueExp. 2</td><td>Significant Genes</td><td>p-valueExp. 1</td></tr><tr><td>Control vs ALC-NTO/ALC-NTC (see legends)</td><td>Growth,Growth Regulation*</td><td><i>GO:0016049</i>GO:0040007</td><td><i>^Cell grow... | <table><tr><td>Comparison</td><td>Keyword</td><td>Gene Set</td><td>Gene Set Description</td><td>Size</td><td>p-valueExp. 2</td><td>Significant Genes</td><td>p-valueExp. 1</td></tr></table> | <table><tr><td>Control vs ALC-NTO/ALC-NTC (see legends)</td><td>Growth,Growth Regulation*</td><td>GO:0016049GO:0040007</td><td>^Cell growth^Growth</td><td>4775</td><td>0.0020.005</td><td>(Ctgf, Igfbp2, Emp1, Osm, Cyr61, Gap43, Crim1, Tgfb3, Igfbp7, Nov, Emp3), Gpc3, Csf1, Socs2, Bmp6, Bmp4, Inhbb, Lepre1, Wrn, Wig1, Ci... |
4d73c2d2b00e5ca864625448a3be5eb728c822e7d31fee8db8ab163b6dbe175a.png | complex | <table><tr><td>Criterion</td><td>Response</td><td>No.</td><td>Mean ± SD</td><td><i>p</i>-Value</td></tr><tr><td colspan="5">Occupational exposure (mean ± SD)</td></tr><tr><td> Yes</td><td>Bone Pb</td><td>108</td><td>14.4 ± 0.50<i><sup>a</sup></i></td><td>< 0.001</td></tr><tr><td> No</td><td></td><td>9... | <table><tr><td>Criterion</td><td>Response</td></tr><tr><td colspan="2">Occupational exposure (mean ± SD)</td></tr><tr><td>Yes</td><td>Bone Pb</td></tr><tr><td>No</td><td></td></tr><tr><td>Yes</td><td>Blood Pb</td></tr><tr><td>No</td><td></td></tr><tr><td colspan="2">Smoked ever/never</td></tr><tr><td>Yes</td><td>Bone P... | <table><tr><td>No.</td><td>Mean ± SD</td><td>p-Value</td></tr><tr><td colspan="3">Occupational exposure (mean ± SD)</td></tr><tr><td>108</td><td>14.4 ± 0.50a</td><td>< 0.001</td></tr><tr><td>99</td><td>3.22 ± 0.50a</td><td></td></tr><tr><td>107</td><td>2.73 ± 2.39</td><td>< 0.001</td></tr><tr><td>98</td><td>1.25 ± 2.10... |
21055bf85d4d94418504e2d72d8836994ea66d62b922b2a22e8f9a1a8bde0037.png | simple | <table><tr><td>Parameter</td><td>(n = 504)</td></tr><tr><td>Age (Years)</td><td></td></tr><tr><td> <50 Years</td><td>422 (84)</td></tr><tr><td> >50 Years</td><td>82(16)</td></tr><tr><td>Sex</td><td></td></tr><tr><td> Male</td><td>423(84)</td></tr><tr><td> Female</td><td>82(16)</td></tr><tr><td>Pre existing comorb... | <table><tr><td>Parameter</td><td>(n = 504)</td></tr><tr><td>Age (Years)</td><td></td></tr><tr><td><50 Years</td><td>422 (84)</td></tr><tr><td>>50 Years</td><td>82(16)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>423(84)</td></tr><tr><td>Female</td><td>82(16)</td></tr><tr><td>Pre existing comorbid conditi... | <table><tr><td>Parameter</td><td>(n = 504)</td></tr><tr><td>espiratory disease</td><td></td></tr><tr><td>Renal Disease</td><td>27 (50)</td></tr><tr><td>Malignancy</td><td>25 (5)</td></tr><tr><td>Hypertension</td><td>11 92)</td></tr><tr><td>Diabetes mellitus</td><td>5 (1)</td></tr><tr><td>Signs and symptoms</td><td></td... |
88a6102a2c1293122652729fa3d016433b71ac73d042de34b08260ab0ad9b992.png | simple | <table><tr><td>Group</td><td><i>n</i></td><td>Before therapy</td><td>After therapy</td></tr><tr><td>Met + Acu Group</td><td>49</td><td>5.57 ± 0.257</td><td>3.23 ± 0.170<sup>***</sup><sup>△△</sup></td></tr><tr><td>Control Group</td><td>49</td><td>5.50 ± 0.244</td><td>4.25 ± 0.197<sup>***<... | <table><tr><td>Group</td><td>n</td><td>Before therapy</td><td>After therapy</td></tr></table> | <table><tr><td>Met + Acu Group</td><td>49</td><td>5.57 ± 0.257</td><td>3.23 ± 0.170***△△</td></tr><tr><td>Control Group</td><td>49</td><td>5.50 ± 0.244</td><td>4.25 ± 0.197***</td></tr></table> |
1695a2c37ec9b6df3ec7321b91cfbdb8c10728154639901259fa9de0b363596a.png | complex | <table><tr><td>Practice related variables</td><td>Percentage (%)</td></tr><tr><td colspan="2">Monitor blood glucose</td></tr><tr><td> Daily</td><td>10 (8)</td></tr><tr><td> Weekly</td><td>18 (15)</td></tr><tr><td> Monthly</td><td>45 (37)</td></tr><tr><td> Never</td><td>49 (40)</td></tr><tr><td colspan="2">Blood pressur... | <table><tr><td>Practice related variables</td><td>Percentage (%)</td></tr></table> | <table><tr><td colspan="2">Monitor blood glucose</td></tr><tr><td>Daily</td><td>10 (8)</td></tr><tr><td>Weekly</td><td>18 (15)</td></tr><tr><td>Monthly</td><td>45 (37)</td></tr><tr><td>Never</td><td>49 (40)</td></tr><tr><td colspan="2">Blood pressure monitor</td></tr><tr><td>Daily</td><td>12 (10)</td></tr><tr><td>Weekl... |
c913ab6b8aee1ac196cb0061bc8c3057c04728ec7558f5474f96abf10e88dfd5.png | complex | <table><tr><td>Species</td><td>Population</td><td>Hostplant</td><td colspan="2">Coordinates</td></tr><tr><td><i>T</i>. <i>bartmani</i></td><td>JL</td><td><i>Abies concolor</i></td><td>34.170000</td><td>-117.002017</td></tr><tr><td><i>T</i>. <i>bartmani</i></td><td>RS</td><td><i>Abies concolor</i></td><td>34.210000</td>... | <table><tr><td>Species</td><td>Population</td><td>Hostplant</td><td colspan="2">Coordinates</td></tr><tr><td>T. bartmani</td><td>JL</td><td>Abies concolor</td><td>34.170000</td><td>-117.002017</td></tr><tr><td>T. bartmani</td><td>RS</td><td>Abies concolor</td><td>34.210000</td><td>-117.098333</td></tr><tr><td>T. bohart... | <table><tr><td>tita</td><td>a</td><td>othus</td><td>58900</td><td>1.900350</td></tr><tr><td>T. petita</td><td>Mo</td><td>Ceanothus</td><td>36.476533</td><td>-121.936133</td></tr><tr><td>T. podura</td><td>HW243</td><td>Adenostoma</td><td>33.815117</td><td>-116.791033</td></tr><tr><td>T. podura</td><td>Seq</td><td>Ceanot... |
860f6b755e8311104a8bb2df4289980a33abcf6752f2a0ba71930425bebca077.png | complex | <table><tr><td rowspan="3">Phenotype</td><td colspan="5">Life-history Classification</td></tr><tr><td colspan="2">Resident Rainbow (RR)</td><td colspan="2">Steelhead Smolt (SS)</td><td><i>P</i></td></tr><tr><td>Mean</td><td>SE</td><td>Mean</td><td>SE</td><td>H<sub>0</sub>: μ<sub>RR</sub> = μ<sub>SS</sub></td>... | <table><tr><td>Phenotype</td><td colspan="5">Life-history Classification</td></tr></table> | <table><tr><td rowspan="2">Phenotype</td><td colspan="2">Resident Rainbow (RR)</td><td colspan="2">Steelhead Smolt (SS)</td><td>P</td></tr><tr><td>Mean</td><td>SE</td><td>Mean</td><td>SE</td><td>H0: μRR = μSS</td></tr><tr><td>Length605</td><td>94.90909</td><td>1.59297</td><td>95.25000</td><td>0.81523</td><td>0.849</td>... |
04c4bf76e8056bc7603921467c731bd9c6e99a773bacff6ff0e47698e514efce.png | complex | <table><tr><td>Sample</td><td>h-IgA Addition (ng/mL)</td><td>Detection (ng/mL)</td><td>Recovery</td></tr><tr><td rowspan="3">1</td><td>0</td><td>190.83</td><td>---</td></tr><tr><td>25</td><td>214.25</td><td>93.7%</td></tr><tr><td>50</td><td>242.25</td><td>102.8%</td></tr><tr><td rowspan="3">2</td><td>0</td><td>218.83</... | <table><tr><td>Sample</td><td>h-IgA Addition (ng/mL)</td><td>Detection (ng/mL)</td><td>Recovery</td></tr><tr><td rowspan="3">1</td><td>0</td><td>190.83</td><td>---</td></tr><tr><td>25</td><td>214.25</td><td>93.7%</td></tr><tr><td>50</td><td>242.25</td><td>102.8%</td></tr><tr><td rowspan="2">2</td><td>0</td><td>218.83</... | <table><tr><td>h-IgA Addition (ng/mL)</td><td>Detection (ng/mL)</td><td>Recovery</td></tr><tr><td>5</td><td>.65</td><td>95.28%</td></tr><tr><td>50</td><td>274.93</td><td>112.2%</td></tr></table> |
1b8549e80ab444f2c3770ca7ff5fb814950d3ae2aed2c7f42e73e11e183af607.png | simple | <table><tr><td>PHASE</td><td>ACTIVITY</td><td>PURPOSE</td><td>LOGISTICS</td><td>PARTICIPANTS</td><td>OUTPUTS</td></tr><tr><td>1.Max.5 × 8hourshifts</td><td>Initial unstructuredobservations</td><td>• Familiarisation with space and use of space• Familiarisation with rhythm of setting• Starting to b... | <table><tr><td>PHASE</td><td>ACTIVITY</td><td>PURPOSE</td><td>LOGISTICS</td><td>PARTICIPANTS</td><td>OUTPUTS</td></tr><tr><td>1.Max.5 × 8hourshifts</td><td>Initial unstructuredobservations</td><td>• Familiarisation with space and use of space• Familiarisation with rhythm of setting• Starting to build relationships and ... | <table><tr><td>PHASE</td><td>ACTIVITY</td><td>PURPOSE</td><td>LOGISTICS</td><td>PARTICIPANTS</td><td>OUTPUTS</td></tr><tr><td>erview</td><td>ews</td><td> what'rules and resources' do they draw on?• Test emerging findings/maps of practices</td><td></td><td>om phase 2</td><td>or analysis</td></tr><tr><td>6.Approx.30 mins... |
a9c90616fb5f5324f02ade9e48d38eeecbd3b9f5f01fc1f0d1a46a5d07515557.png | complex | <table><tr><td>Variables</td><td colspan="2">CU<sup>c</sup> (<i>N</i> = 35)</td><td colspan="2">nCU<sup>d</sup> (<i>N</i> = 48)</td><td><i>t</i></td><td><i>p</i></td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td></td><td></td></tr><tr><td>Age</td><td>22.51</td><td>5.63</td><td>21.67</td><td>3.56... | <table><tr><td>Variables</td><td colspan="2">CUc (N = 35)</td><td colspan="2">nCUd (N = 48)</td><td>t</td><td>p</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td></td><td></td></tr><tr><td>Age</td><td>22.51</td><td>5.63</td><td>21.67</td><td>3.56</td><td>0.84</td><td>0.40</td></tr><tr><td>UnExa<... | <table><tr><td>Variables</td><td colspan="2">CUc (N = 35)</td><td colspan="2">nCUd (N = 48)</td><td>t</td><td>p</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td></td><td></td></tr><tr><td>CogDisb</td><td>10.46</td><td>5.75</td><td>10.73</td><td>4.97</td><td>−0.23</td><td>0.82</td></tr><tr><td>C... |
cd3aef7a3f0331c4bed474aee5472084639cbd3a7d9000a8d04a9fb0897276d0.png | complex | <table><tr><td colspan="2"><i>ERAP2</i> genotype</td><td colspan="3">Fetal</td><td colspan="3">Maternal</td><td colspan="3">Total</td></tr><tr><td>rs2248374</td><td>rs2549782</td><td>Observed</td><td>Expected</td><td><i>P</i>-value</td><td>Observed</td><td>Expected</td><td><i>P</i>-value</td><td>Observed</td><td>Expect... | <table><tr><td colspan="2">ERAP2 genotype</td><td colspan="3">Fetal</td><td colspan="3">Maternal</td><td colspan="3">Total</td></tr><tr><td>rs2248374</td><td>rs2549782</td><td>Observed</td><td>Expected</td><td>P-value</td><td>Observed</td><td>Expected</td><td>P-value</td><td>Observed</td><td>Expected</td><td>P-value</t... | <table><tr><td>GG</td><td>6</td><td>215</td><td> e-10</td><td>50</td><td>4</td><td>1</td><td>429</td><td>16</td></tr></table> |
c3c4ee41f6c5ecde619048415fe5a3bd81fd9ab5cacbe7343b89357fd8b11c7b.png | complex | <table><tr><td colspan="2"></td><td colspan="5">Mycotoxin Content (μg/kg) <sup>a</sup></td></tr><tr><td></td><td>% >LOD</td><td>Mean</td><td>SEM <sup>b</sup></td><td>Median</td><td>90th Percentile</td><td>Maximum</td></tr><tr><td>DON</td><td>66</td><td>473</td><td>99</td><td>100</td><td>2510</td><td>9880</td></... | <table><tr><td colspan="2"></td><td colspan="5">Mycotoxin Content (μg/kg) a</td></tr><tr><td></td><td>% >LOD</td><td>Mean</td><td>SEM b</td><td>Median</td><td>90th Percentile</td><td>Maximum</td></tr><tr><td>DON</td><td>66</td><td>473</td><td>99</td><td>100</td><td>2510</td><td>9880</td></tr><tr><td>ZEA</td><td>22</td>... | <table><tr><td>NIV</td><td>25</td><td>16</td><td>3</td><td>3</td><td>75</td><td>290</td></tr></table> |
2904c6b03c61086147d06a53317ec618739c7ea753be8f3eae4c9c1e1dc4a9a5.png | complex | <table><tr><td>Country</td><td>Discount</td><td>Annual cash flow (profit/loss)</td><td>Present value of annual cash flow</td><td>Present value of all annual cash flows</td><td>Present value of terminal value<sup>a</sup></td><td>Total present value<sup>b</sup></td></tr><tr><td rowspan="3">Singapore</td><td>50% annually<... | <table><tr><td>Country</td><td>Discount</td><td>Annual cash flow (profit/loss)</td><td>Present value of annual cash flow</td><td>Present value of all annual cash flows</td><td>Present value of terminal valuea</td><td>Total present valueb</td></tr><tr><td rowspan="3">Singapore</td><td>50% annually</td><td>3.13</td><td>0... | <table><tr><td>Country</td><td>Discount</td><td>Annual cash flow (profit/loss)</td><td>Present value of annual cash flow</td><td>Present value of all annual cash flows</td><td>Present value of terminal valuea</td><td>Total present valueb</td></tr><tr><td rowspan="3">USA</td><td>50% annually</td><td>−94.76</td><td>0</td... |
e1be260af39ff0e3bf43390e73da0257c46f66c0ecc255438ecdb98f478b3ee9.png | simple | <table><tr><td>Order</td><td> Symbol</td><td>Name</td><td>Similarity</td><td>Parameter</td><td>Remark</td></tr><tr><td>1</td><td>CENP-E</td><td>kinesin</td><td>0. 8169</td><td>3</td><td> </td></tr><tr><td>2</td><td>GCN4</td><td> </td><td>0.7611</td><td>3</td><td>monomer yeast transcriptional activator</td></tr><tr><td>... | <table><tr><td>Order</td><td>Symbol</td></tr><tr><td>1</td><td>CENP-E</td></tr><tr><td>2</td><td>GCN4</td></tr><tr><td>3</td><td>ROCK1</td></tr><tr><td>6</td><td>CENP-B</td></tr><tr><td>4</td><td>PAK1</td></tr><tr><td>7</td><td>GP41-HIV</td></tr><tr><td>8</td><td>ATG12</td></tr><tr><td>5</td><td>ROCK2</td></tr><tr><td>... | <table><tr><td>Name</td><td>Similarity</td><td>Parameter</td><td>Remark</td></tr><tr><td>kinesin</td><td>0. 8169</td><td>3</td><td></td></tr><tr><td></td><td>0.7611</td><td>3</td><td>monomer yeast transcriptional activator</td></tr><tr><td>Serine kinase</td><td>0.7394</td><td>3</td><td>Rho-associated,coiled-coil contai... |
0a5bc461fdd8bf0046ad3b199a282049d5d156cec063036b101bb5218043b0aa.png | simple | <table><tr><td></td><td></td><td>high secure-intensive care</td><td>Male admission/high secure</td><td>Male medium secure-1</td><td>Male medium secure-2</td><td>Long term low security</td><td>Male low secure rehab</td><td>Male pre-discharge/community h1gh support</td><td>ANOVADf = 6</td></tr><tr><td>N</td><td></td><td>... | <table><tr><td></td><td></td><td>high secure-intensive care</td><td>Male admission/high secure</td><td>Male medium secure-1</td><td>Male medium secure-2</td><td>Long term low security</td><td>Male low secure rehab</td><td>Male pre-discharge/community h1gh support</td><td>ANOVADf = 6</td></tr></table> | <table><tr><td>N</td><td></td><td>7</td><td>10</td><td>14</td><td>16</td><td>10</td><td>15</td><td>15</td><td>F/p</td></tr><tr><td>GAF</td><td>mean</td><td>34.6</td><td>45.8</td><td>47.4</td><td>54.4</td><td>47.8</td><td>60.5</td><td>73</td><td>13.8/0.001</td></tr><tr><td></td><td>95% CI</td><td>20.3-48.8</td><td>35.3-... |
2420ef2c057ef530a1f23322e68f8978665b3a21e8cd928abbb197dfc6ce6926.png | simple | <table><tr><td>Measurement<sup>a</sup></td><td>No. (%)</td></tr><tr><td>Range of motion (knee)</td><td>34 (57)</td></tr><tr><td>X-ray (knee)</td><td>19 (32)</td></tr><tr><td>Pain score (knee)</td><td>10 (17)</td></tr><tr><td>Subjects were asked to first stand and then walk along a 10 m walkway</td><td>5 (8)</td></tr><t... | <table><tr><td>Measurementa</td><td>No. (%)</td></tr><tr><td>Range of motion (knee)</td><td>34 (57)</td></tr><tr><td>X-ray (knee)</td><td>19 (32)</td></tr><tr><td>Pain score (knee)</td><td>10 (17)</td></tr><tr><td>Subjects were asked to first stand and then walk along a 10 m walkway</td><td>5 (8)</td></tr><tr><td>Range... | <table><tr><td>Measurementa</td><td>No. (%)</td></tr><tr><td>Chair rise test</td><td>2 (3)</td></tr><tr><td>Muscle power (shoulder)</td><td>2 (3)</td></tr><tr><td>Range of motion (ankle)</td><td>2 (3)</td></tr><tr><td>Range of motion (finger/wrist)</td><td>2 (3)</td></tr><tr><td>Range of motion (lower limb, matching ta... |
24272b6514eb993ce01aa88bf28a7cf2931d1f0d836e476e521738d38b83c7ac.png | simple | <table><tr><td>Compound</td><td>Adsorption capacity, μmol g<sup>−1</sup></td><td>Distribution coefficient (<i>k</i>), g L<sup>−1</sup></td></tr><tr><td>1-Naphthol</td><td>62</td><td>200</td></tr><tr><td>2-Naphthol</td><td>60</td><td>170</td></tr><tr><td>Resorcinol</td><td>59</td><td>190</td></tr><tr><t... | <table><tr><td>Compound</td><td>Adsorption capacity, μmol g−1</td></tr><tr><td>1-Naphthol</td><td>62</td></tr><tr><td>2-Naphthol</td><td>60</td></tr><tr><td>Resorcinol</td><td>59</td></tr><tr><td>Phenol</td><td>0 ± 2</td></tr></table> | <table><tr><td>Distribution coefficient (k), g L−1</td></tr><tr><td>200</td></tr><tr><td>170</td></tr><tr><td>190</td></tr><tr><td>–</td></tr></table> |
7c771c9b7d017b7a4e93047436ddc7bc9e4866c24ddcb1e723efc2ede46ebe38.png | complex | <table><tr><td>Characteristic</td><td>Value</td><td>ICUSteps</td><td>UCCDIP</td><td>Verbal</td><td>Total</td><td>p Value</td></tr><tr><td>Age (years)</td><td>Mean±SD</td><td>59±15.26</td><td>60±15.19</td><td>61±17.48</td><td>60±16.04</td><td>0.72</td></tr><tr><td>Ethnicity (white British)</td><... | <table><tr><td>Characteristic</td><td>Value</td><td>ICUSteps</td><td>UCCDIP</td><td>Verbal</td><td>Total</td><td>p Value</td></tr><tr><td>Age (years)</td><td>Mean±SD</td><td>59±15.26</td><td>60±15.19</td><td>61±17.48</td><td>60±16.04</td><td>0.72</td></tr><tr><td>Ethnicity (white British)</td><td>n (%)</td><td>34 (71)<... | <table><tr><td rowspan="2">APACHE II score</td><td>ICU admissionMedian (range)</td><td>17 (24)</td><td>18.0 (30)</td><td>16.0 (29)</td><td>17.0 (30)</td><td>0.41</td></tr><tr><td>ICU discharge Median (range)</td><td>8.0 (20)</td><td>9.5 (20)</td><td>9.0 (21)</td><td>9.0 (21)</td><td>0.66</td></tr><tr><td rowspan="2">Le... |
5e3fdeb3784f3a0b98619228bb7b7a82e293fcb24cdf3afc15a18f6aeb8f4cab.png | simple | <table><tr><td></td><td>Group 1</td><td>Group 2</td><td>Chi-square</td><td>Significance (p value)</td></tr><tr><td>A</td><td>123/339 (36.3 %)</td><td>84/370 (22.7 %)</td><td>15.784</td><td><0.001</td></tr><tr><td>B</td><td>146/339 (43.1 %)</td><td>99/370 (26.8 %)</td><td>20.813</td><td><0.001</td></tr><tr><td>C</... | <table><tr><td></td><td>Group 1</td><td>Group 2</td><td>Chi-square</td><td>Significance (p value)</td></tr></table> | <table><tr><td>A</td><td>123/339 (36.3 %)</td><td>84/370 (22.7 %)</td><td>15.784</td><td><0.001</td></tr><tr><td>B</td><td>146/339 (43.1 %)</td><td>99/370 (26.8 %)</td><td>20.813</td><td><0.001</td></tr><tr><td>C</td><td>14/339 (4.1 %)</td><td>19/370 (5.1 %)</td><td>0.403</td><td>0.594</td></tr><tr><td>D</td><td>144/33... |
710b858fb2cb5cbe044cfcbd2ad6d6ba6a4cf624d3ffd03b0ebfaa812fec01ba.png | complex | <table><tr><td></td><td colspan="5">Seroprotection status</td><td></td></tr><tr><td>Vaccine strain</td><td></td><td colspan="2">Young cohort (<i>n</i> = 58)</td><td colspan="2">Older cohort (<i>n</i> = 54)</td><td><i>p</i></td></tr><tr><td></td><td></td><td>Placebo</td><td><i>B. longum</i> + Gl-OS</td><td>Placebo</td><... | <table><tr><td></td><td colspan="2">Seroprotection status</td></tr><tr><td>Vaccine strain</td><td></td><td>Young cohort (n = 58)</td></tr><tr><td></td><td></td><td>Placebo</td></tr><tr><td></td><td></td><td>n/N (%)</td></tr><tr><td rowspan="2">A/California/7/2009 (H1N1)</td><td>Before</td><td>20/29 (69)a</td></tr><tr><... | <table><tr><td colspan="3">Seroprotection status</td><td></td></tr><tr><td>Young cohort (n = 58)</td><td colspan="2">Older cohort (n = 54)</td><td>p</td></tr><tr><td>B. longum + Gl-OS</td><td>Placebo</td><td>B. longum + Gl-OS</td><td></td></tr><tr><td>n/N (%)</td><td>n/N (%)</td><td>n/N (%)</td><td></td></tr><tr><td>13... |
945efc775b00d125bcd4fead53b408298336c3fb8ed93532f39a7ffadafa0678.png | simple | <table><tr><td>Sampling date</td><td>ACE</td><td><i>Chao</i>1</td><td>Shannon diversity (<i>H</i><i>'</i>)</td><td>Simpson diversity (1/<i>D</i>)</td></tr><tr><td>Jul. 13</td><td>383(363,415)</td><td>386(361,433)</td><td>3.58(3.55,3.62)</td><td>11(11,11)</td></tr><tr><td>Jul. 31</td><td>409(386,445)</td><td>405(380,451... | <table><tr><td>Sampling date</td><td>ACE</td><td>Chao1</td><td>Shannon diversity (H')</td><td>Simpson diversity (1/D)</td></tr><tr><td>Jul. 13</td><td>383(363,415)</td><td>386(361,433)</td><td>3.58(3.55,3.62)</td><td>11(11,11)</td></tr><tr><td>Jul. 31</td><td>409(386,445)</td><td>405(380,451)</td><td>4.19(4.16,4.22)</t... | <table><tr><td>Sampling date</td><td>ACE</td><td>Chao1</td><td>Shannon diversity (H')</td><td>Simpson diversity (1/D)</td></tr><tr><td>Sep. 30</td><td>401(381,435)</td><td>399(375,442)</td><td>4.43(4.39,4.46)</td><td>33(33,33)</td></tr></table> |
8d706275f8cb4e01b9257fa67b3b5f88de8d527909879c06ad5183eef3c45252.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Creatinine-Cystatin C-based eGFR, ml/min/1.73 m<sup>2</sup></td><td colspan="3">C-reactive protein levels, mg/L</td></tr><tr><td>≥60(<i>n</i> = 1750)</td><td><60(<i>n</i> = 605)</td><td><i>P</i>-value</td><td><3(<i>n</i> = 1564)</td><td>≥3(<i>n</i> = 791... | <table><tr><td rowspan="2"></td><td colspan="3">Creatinine-Cystatin C-based eGFR, ml/min/1.73 m2</td><td colspan="3">C-reactive protein levels, mg/L</td></tr><tr><td>≥60(n = 1750)</td><td><60(n = 605)</td><td>P-value</td><td><3(n = 1564)</td><td>≥3(n = 791)</td><td>P-value</td></tr><tr><td>Age, years</td><td>71.2 ± 5.0... | <table><tr><td rowspan="2"></td><td colspan="3">Creatinine-Cystatin C-based eGFR, ml/min/1.73 m2</td><td colspan="3">C-reactive protein levels, mg/L</td></tr><tr><td>≥60(n = 1750)</td><td><60(n = 605)</td><td>P-value</td><td><3(n = 1564)</td><td>≥3(n = 791)</td><td>P-value</td></tr><tr><td>Serum cystatin C, mg/L</td><t... |
2d15ef3dc7d01f9d84b73dd1b4e01f8f28c8bd30ccda70a0f48ad2cf03685d83.png | complex | <table><tr><td>Analyte</td><td colspan="2">Plasma</td><td colspan="2">CSF</td></tr><tr><td> </td><td>Sensitivity (pg/mL)</td><td>Inter-assay CV range (QC concentration range)</td><td>Sensitivity (pg/mL)</td><td>Inter-assay CV range (QC concentration range)</td></tr><tr><td>IL-1Ra</td><td>16</td><td>8.2 to 3.2 (360 to 1... | <table><tr><td>Analyte</td><td colspan="2">Plasma</td></tr><tr><td></td><td>Sensitivity (pg/mL)</td><td>Inter-assay CV range (QC concentration range)</td></tr><tr><td>IL-1Ra</td><td>16</td><td>8.2 to 3.2 (360 to 10,009 pg/mL)</td></tr><tr><td>IL-1α</td><td>6.1</td><td>9.0 to 4.2 (25 to 366 pg/mL)</td></tr><tr><td>IL-1β... | <table><tr><td colspan="2">CSF</td></tr><tr><td>Sensitivity (pg/mL)</td><td>Inter-assay CV range (QC concentration range)</td></tr><tr><td colspan="2">Same assay as for plasma</td></tr><tr><td>4.75</td><td>6.6 to 9.2 (20 to 800 pg/mL)</td></tr><tr><td>0.48</td><td>30.3 to 10.9 (1.3 to 10.9 pg/mL)</td></tr><tr><td>17</t... |
21f8c13735908508ee03bd3d8c76592810091da2451173c895807ba1ae486b86.png | complex | <table><tr><td rowspan="2">Age (years)</td><td colspan="2">MDI/FSIQ < 85</td><td colspan="2">Externalizing Problems ≥ 60</td><td colspan="2">Hyperactivity subscale ≥ 60</td><td colspan="2">Behavioral Symptoms Index ≥ 60</td></tr><tr><td><i>n</i> (%) </td><td>OR (95% CI) </td><td><i>n</i> (%) </td><... | <table><tr><td rowspan="2">Age (years)</td><td colspan="2">MDI/FSIQ < 85</td><td colspan="2">Externalizing Problems ≥ 60</td><td colspan="2">Hyperactivity subscale ≥ 60</td><td colspan="2">Behavioral Symptoms Index ≥ 60</td></tr><tr><td>n (%)</td><td>OR (95% CI)</td><td>n (%)</td><td>OR (95% CI)</td><td>n (%)</td><td>O... | <table><tr><td>4</td><td>—</td><td>—</td><td>17 (10.30)</td><td>1.51 (0.44, 5.21)</td><td>17 (10.30)</td><td>2.22 (0.55, 9.01)</td><td>13 (7.88)</td><td>2.02 (0.49, 8.39)</td></tr><tr><td>5</td><td>25 (13.97)</td><td>1.70 (0.36, 7.94)</td><td>17 (9.29)</td><td>2.66 (0.47, 15.06)</td><td>19 (10.38)</td><td>4.45 (1.31, 1... |
a573812a3d91fc4ca4ae16cfe2e70610853516f47f9655d1b3a86efdb87a099f.png | complex | <table><tr><td></td><td>Variables</td><td>Prevalence (95% CI)</td><td>Crude OR (95% CI)</td><td>Wald</td><td>Adjusted OR<sup>a</sup> (95%CI)</td><td><i>p</i> value</td></tr><tr><td rowspan="2">Locality</td><td>Urban</td><td>38.44 (35.60, 41.37)</td><td>R</td><td></td><td></td><td></td></tr><tr><td>Rural</td><td>44.04 (... | <table><tr><td></td><td>Variables</td><td>Prevalence (95% CI)</td><td>Crude OR (95% CI)</td><td>Wald</td><td>Adjusted ORa (95%CI)</td><td>p value</td></tr><tr><td rowspan="2">Locality</td><td>Urban</td><td>38.44 (35.60, 41.37)</td><td>R</td><td></td><td></td><td></td></tr><tr><td>Rural</td><td>44.04 (40.55, 47.60)</td>... | <table><tr><td rowspan="3">Ethnicity</td><td>Indian</td><td>40.74 (32.82, 49.16)</td><td>1.05 (0.80, 1.39)</td><td></td><td></td><td></td></tr><tr><td>Other Bumiputera</td><td>56.46 (49.04, 63.61)</td><td>2.05 (1.59, 2.66)</td><td></td><td></td><td></td></tr><tr><td>Others</td><td>39.89 (24.11, 58.09)</td><td>0.76 (0.4... |
1af9eb20043a38f00c3b6441d636f7fbb2d8ad5f26987eebf6f12cde828418e4.png | simple | <table><tr><td>SSRMarker</td><td>Motif</td><td>SSR Location</td><td>LG</td><td><i>n</i><sub><i>B</i></sub></td><td><i>n</i><sub><i>F</i></sub></td><td><i>n</i><sub><i>H</i></sub></td><td><i>n</i><sub><i>N</i></sub></td><td><i>n</i><sub><i>L</i></sub></td><td><i>h</i><sub><i>B</i></sub></td><td><i>h</i><sub><i>F</i></su... | <table><tr><td>SSRMarker</td><td>Motif</td><td>SSR Location</td><td>LG</td><td>nB</td><td>nF</td><td>nH</td><td>nN</td><td>nL</td><td>hB</td><td>hF</td><td>hH</td><td>hN</td><td>hL</td></tr><tr><td>IM27</td><td>(AAG)12</td><td>5' UTR</td><td>18</td><td>2</td><td>1</td><td>1</td><td>1</td><td>4</td><td>0.24</td><td>0.00... | <table><tr><td>SSRMarker</td><td>Motif</td><td>SSR Location</td><td>LG</td><td>nB</td><td>nF</td><td>nH</td><td>nN</td><td>nL</td><td>hB</td><td>hF</td><td>hH</td><td>hN</td><td>hL</td></tr><tr><td>IM503</td><td>(CT)12</td><td>5' UTR</td><td>10</td><td>7</td><td>6</td><td>5</td><td>7</td><td>18</td><td>0.82</td><td>0.8... |
f4b3c1b3609b06c96e3a1df28e2160395a54505bc2f48023a3d3775258f0a27f.png | complex | <table><tr><td rowspan="2">Serum samples against:</td><td rowspan="2">Clade</td><td colspan="2">HI titer (log<sub>2</sub>) against</td><td rowspan="2">HA identity*</td></tr><tr><td>TK16</td><td>Homologous antigen</td></tr><tr><td>A/chicken/Egypt/AR234-FAOF8NLQP/2014 (H5N1)</td><td>2.2.1.2</td><td>7</td><td>9</td><td>99... | <table><tr><td rowspan="2">Serum samples against:</td><td rowspan="2">Clade</td><td colspan="2">HI titer (log2) against</td><td rowspan="2">HA identity*</td></tr><tr><td>TK16</td><td>Homologous antigen</td></tr><tr><td>A/chicken/Egypt/AR234-FAOF8NLQP/2014 (H5N1)</td><td>2.2.1.2</td><td>7</td><td>9</td><td>99.4/100</td>... | <table><tr><td rowspan="2">Serum samples against:</td><td rowspan="2">Clade</td><td colspan="2">HI titer (log2) against</td><td rowspan="2">HA identity*</td></tr><tr><td>TK16</td><td>Homologous antigen</td></tr><tr><td>A/teal/Germany/WV632/2005 (H5N1)</td><td>2.2</td><td>6</td><td>9</td><td>88.7/90.6</td></tr><tr><td>A... |
a7c6f02d7b2e5b7e58efb7e2df9d0dadb1d8ed32b699c7909ff74165ec8c2252.png | complex | <table><tr><td> </td><td colspan="2"> </td><td>BMI</td><td>Age</td><td>12-month</td></tr><tr><td>DSM-5 diagnosis</td><td>N</td><td>%</td><td><i>M</i> (<i>SD</i>)</td><td><i>M</i> (<i>SD</i>)</td><td>N</td></tr><tr><td>RAN</td><td>364</td><td>16.3</td><td>16.1 (1.6)</td><td>23.2 (6.6)</td><td>102</td></tr><tr><td>ANB/P<... | <table><tr><td></td><td colspan="2"></td><td>BMI</td><td>Age</td><td>12-month</td></tr><tr><td>DSM-5 diagnosis</td><td>N</td><td>%</td><td>M (SD)</td><td>M (SD)</td><td>N</td></tr><tr><td>RAN</td><td>364</td><td>16.3</td><td>16.1 (1.6)</td><td>23.2 (6.6)</td><td>102</td></tr><tr><td>ANB/P</td><td>295</td><td>13.2</td><... | <table><tr><td>Sub BED</td><td>11</td><td>0.5</td><td>30.2 (7.6)</td><td>34.4 (13.2)</td><td>-</td></tr><tr><td>PD</td><td>184</td><td>8.2</td><td>21.9 (3.5)</td><td>25.4 (7.9)</td><td>39</td></tr><tr><td>UFED</td><td>71</td><td>3.2</td><td>19.9 (6.7)</td><td>26.1 (9.1)</td><td>12</td></tr></table> |
38b11761a70edb96ee12d5446a1c1dbcb957814107560ec4df9e8e7a9fd330c9.png | simple | <table><tr><td>Pseudo-chromosome</td><td>No. of SNPs</td><td>No. of InDels</td><td>No. of SSRs</td><td>Physical size (Mb)</td></tr><tr><td>Pseudo-chromosome 1</td><td>25,395 (941)</td><td>596 (22)</td><td>798 (30)</td><td>26.8</td></tr><tr><td>Pseudo-chromosome 2</td><td>40,350 (961)</td><td>895 (21)</td><td>1,376 (33)... | <table><tr><td>Pseudo-chromosome</td><td>No. of SNPs</td><td>No. of InDels</td><td>No. of SSRs</td><td>Physical size (Mb)</td></tr><tr><td>Pseudo-chromosome 1</td><td>25,395 (941)</td><td>596 (22)</td><td>798 (30)</td><td>26.8</td></tr><tr><td>Pseudo-chromosome 2</td><td>40,350 (961)</td><td>895 (21)</td><td>1,376 (33)... | <table><tr><td>Pseudo-chromosome 6</td><td>19,016 (906)</td><td>516 (25)</td><td>584 (27)</td><td>21.3</td></tr><tr><td>Pseudo-chromosome 7</td><td>14,219 (836)</td><td>344 (20)</td><td>562 (33)</td><td>17.1</td></tr><tr><td>Pseudo-chromosome 8</td><td>11,360 (668)</td><td>452 (27)</td><td>502 (29)</td><td>17.3</td></t... |
50a004196def1e0b92b64464b65d59f2ca02c4816625cdf807881aa3373596ee.png | simple | <table><tr><td>Parameters</td><td>Pre-treatment</td><td>First weekpost-treatment</td><td>Second weekpost-treatment</td></tr><tr><td>Volume of ejaculate (ml)</td><td>0.30 ± 0.02 *</td><td>0.23 ± 0.02</td><td>0.15 ± 0.02*</td></tr><tr><td>Color of ejaculate</td><td>Milky to creamy white</td><td>Milky to cr... | <table><tr><td>Parameters</td><td>Pre-treatment</td><td>First weekpost-treatment</td><td>Second weekpost-treatment</td></tr><tr><td>Volume of ejaculate (ml)</td><td>0.30 ± 0.02 *</td><td>0.23 ± 0.02</td><td>0.15 ± 0.02*</td></tr><tr><td>Color of ejaculate</td><td>Milky to creamy white</td><td>Milky to creamy white</td>... | <table><tr><td>Sperm motility</td><td>85% *</td><td>80%</td><td>70% *</td></tr><tr><td>Spermatozoa viability</td><td>96% *</td><td>90%</td><td>83% *</td></tr><tr><td>Sperm concentration (x 109/ml)</td><td>428 ± 4.26 *</td><td>341 ± 6.63 *</td><td>289 ± 4.81*</td></tr></table> |
4ca2c18a1088ef058fbf7129c61af7fe7eb35c7a0eee41aecfbf73b42fc645d5.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Analysis with CCP score</td><td colspan="2">Analysis with mPS</td></tr><tr><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>CCP score</td><td>1.60 (1.14, 2.24)</td><td>0.006</td><td></td><td></t... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Analysis with CCP score</td><td colspan="2">Analysis with mPS</td></tr><tr><td>Hazard ratio (95% CI)</td><td>P value</td><td>Hazard ratio (95% CI)</td><td>P value</td></tr><tr><td>CCP score</td><td>1.60 (1.14, 2.24)</td><td>0.006</td><td></td><td></td></tr><tr><td... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Analysis with CCP score</td><td colspan="2">Analysis with mPS</td></tr><tr><td>Hazard ratio (95% CI)</td><td>P value</td><td>Hazard ratio (95% CI)</td><td>P value</td></tr><tr><td>Segmentectomy</td><td>3.31 (1.62, 6.30)</td><td></td><td>3.31 (1.62, 6.30)</td><td><... |
95813bd7ed8769b0d9091de957b0b4ebe139a784b097f154823058aff67901d4.png | complex | <table><tr><td colspan="2">Variable</td><td>N° total dogs</td><td>N° positive<i>T. annae</i>dog (%)</td></tr><tr><td rowspan="3">Age (years)</td><td>≤3</td><td>65</td><td>53 (81.54)**</td></tr><tr><td>>3</td><td>47</td><td>22 (46.81)</td></tr><tr><td>unknown</td><td>8</td><td>0</td></tr><tr><td rowsp... | <table><tr><td colspan="2">Variable</td><td>N° total dogs</td><td>N° positiveT. annaedog (%)</td></tr><tr><td rowspan="3">Age (years)</td><td>≤3</td><td>65</td><td>53 (81.54)**</td></tr><tr><td>>3</td><td>47</td><td>22 (46.81)</td></tr><tr><td>unknown</td><td>8</td><td>0</td></tr><tr><td rowspan="3">Sex</td><td>Male</t... | <table><tr><td>Lifestyle</td><td>unknown</td><td>5</td><td>0</td></tr><tr><td rowspan="2">Habitat</td><td>Rural</td><td>96</td><td>64 (66.6)</td></tr><tr><td>Urban</td><td>24</td><td>11 (45.8)</td></tr><tr><td rowspan="3">Tick infestation</td><td>Yes</td><td>50</td><td>35 (70)</td></tr><tr><td>No</td><td>49</td><td>27 ... |
53024b889399690f2c75e3e4f72a2422214711512498fd144db9c72b9d6d2c03.png | simple | <table><tr><td>Parameter</td><td>Correlation coefficient (<i>r</i>)</td><td><i>p</i> value</td></tr><tr><td>CD11a<i>vs.</i>sICAM-1</td><td>0.317</td><td>>0.01</td></tr><tr><td>CD11a<i>vs.</i>sVCAM-1</td><td>0.366</td><td>> 0.01</td></tr><tr><td>CD11b<i>vs.</i>sICAM-1</td><td>0.251</td><td>> 0.05</td></tr><tr><... | <table><tr><td>Parameter</td><td>Correlation coefficient (r)</td><td>p value</td></tr><tr><td>CD11avs.sICAM-1</td><td>0.317</td><td>>0.01</td></tr><tr><td>CD11avs.sVCAM-1</td><td>0.366</td><td>> 0.01</td></tr><tr><td>CD11bvs.sICAM-1</td><td>0.251</td><td>> 0.05</td></tr><tr><td>CD11bvs. sVCAM-1</td><td>0.258</td><td>> ... | <table><tr><td>ICAM-1</td><td>5</td><td>>0.01</td></tr><tr><td>CD49dvs.sVCAM-1</td><td>0.419</td><td>> 0.01</td></tr><tr><td>sICAM-1vs.TNF-α</td><td>0.355</td><td>>0.01</td></tr><tr><td>sVCAM-1vs.TNF-α</td><td>0.419</td><td>> 0.01</td></tr></table> |
7a12717cb8e914bb1aff7e249d7ec262962423e79a0c5120c91ace0cb978b612.png | complex | <table><tr><td>Male</td><td>60 (67%)</td></tr><tr><td colspan="2">Age</td></tr><tr><td> 20–40 years of age</td><td>52 (58%)</td></tr><tr><td> 41–50 years of age</td><td>21 (23%)</td></tr><tr><td> >50 years of age</td><td>17 (19%)</td></tr><tr><td colspan="2">Practitioner type</td></tr><tr><td> Attending ... | <table><tr><td>Male</td><td>60 (67%)</td></tr><tr><td colspan="2">Age</td></tr><tr><td>20–40 years of age</td><td>52 (58%)</td></tr><tr><td>41–50 years of age</td><td>21 (23%)</td></tr><tr><td>>50 years of age</td><td>17 (19%)</td></tr><tr><td colspan="2">Practitioner type</td></tr><tr><td>Attending physician</td><td>5... | <table><tr><td>Resident</td><td>13 (14%)</td></tr><tr><td>Extender</td><td>21 (23%)</td></tr><tr><td colspan="2">Experience</td></tr><tr><td>1–5 years</td><td>38 (42%)</td></tr><tr><td>>5–10 years</td><td>15 (17%)</td></tr><tr><td>>10 years</td><td>37 (41%)</td></tr><tr><td colspan="2">Practice facility</td></tr><tr><t... |
8540d8024c206921be19b14137e08d9c442dcab253d563eb29bd24e31fa2ffcc.png | simple | <table><tr><td>Parameter</td><td>South Asian</td><td>Western European</td><td><i>p</i>-value</td></tr><tr><td>WB SAS</td><td>0.7 ± 0.8</td><td>1.8 ± 2.3</td><td>0.10</td></tr><tr><td>Head/neck SAS</td><td>0.5 ± 1.1</td><td>1.9 ± 4.0</td><td>0.21</td></tr><tr><td>Aorta SAS</td><td>0.9 ± 2.6</td>... | <table><tr><td>Parameter</td><td>South Asian</td></tr><tr><td>WB SAS</td><td>0.7 ± 0.8</td></tr><tr><td>Head/neck SAS</td><td>0.5 ± 1.1</td></tr><tr><td>Aorta SAS</td><td>0.9 ± 2.6</td></tr><tr><td>Abdomen SAS</td><td>1.8 ± 3.8</td></tr><tr><td>Iliofemoral SAS</td><td>0.0 ± 0.0</td></tr><tr><td>Run-off SAS</td><td>0.7 ... | <table><tr><td>Western European</td><td>p-value</td></tr><tr><td>1.8 ± 2.3</td><td>0.10</td></tr><tr><td>1.9 ± 4.0</td><td>0.21</td></tr><tr><td>1.3 ± 3.1</td><td>0.59</td></tr><tr><td>3.2 ± 4.4</td><td>0.26</td></tr><tr><td>1.9 ± 6.9</td><td>0.048</td></tr><tr><td>0.9 ± 2.9</td><td>0.77</td></tr><tr><td>1117 (95%)</td... |
80ef5e308c1267fa5ad1a7186977032ba58dfae80090ee663433301f38f3ff68.png | complex | <table><tr><td rowspan="2">Occupational exposure</td><td colspan="2">Never smokers</td><td colspan="2">Former smokers</td><td colspan="2">Current smokers</td><td rowspan="2"><i>P</i> value<sup>b</sup></td></tr><tr><td>No.</td><td>%</td><td>No.</td><td>%</td><td>No.</td><td>%</td></tr><tr><td>Never exposed</td><td>52</t... | <table><tr><td rowspan="2">Occupational exposure</td><td colspan="2">Never smokers</td><td>Former smokers</td></tr><tr><td>No.</td><td>%</td><td>No.</td></tr><tr><td>Never exposed</td><td>52</td><td>70.3</td><td>38</td></tr><tr><td>Ever exposed (any agent)</td><td>22</td><td>29.7</td><td>40</td></tr><tr><td>Wood dust</... | <table><tr><td>Former smokers</td><td colspan="2">Current smokers</td><td rowspan="2">P valueb</td></tr><tr><td>%</td><td>No.</td><td>%</td></tr><tr><td>48.7</td><td>32</td><td>69.6</td><td>Reference</td></tr><tr><td>51.3</td><td>14</td><td>30.4</td><td>0.01</td></tr><tr><td>26.9</td><td>10</td><td>21.7</td><td>0.10</t... |
75c73fd1c54ef007e92d97ac06a8f88014224584fc33dca89fd5a645322c1e68.png | complex | <table><tr><td>Product</td><td>Batch</td><td>Nonfucosylated (%)</td><td>Hybrid (%)</td><td>Sialylated (%)</td><td>Galactosylated (%)</td><td>High mannose (%)</td></tr><tr><td rowspan="3">MabThera</td><td>H0605</td><td>1.81 ± 0.04</td><td>5.00 ± 0.32</td><td>0.72 ± 0.08</td><td>43.34 ± 1.42</td><td>4... | <table><tr><td>Product</td><td>Batch</td><td>Nonfucosylated (%)</td><td>Hybrid (%)</td><td>Sialylated (%)</td><td>Galactosylated (%)</td><td>High mannose (%)</td></tr><tr><td rowspan="2">MabThera</td><td>H0605</td><td>1.81 ± 0.04</td><td>5.00 ± 0.32</td><td>0.72 ± 0.08</td><td>43.34 ± 1.42</td><td>4.37 ± 0.42</td></tr>... | <table><tr><td>Product</td><td>Batch</td><td>Nonfucosylated (%)</td><td>Hybrid (%)</td><td>Sialylated (%)</td><td>Galactosylated (%)</td><td>High mannose (%)</td></tr><tr><td>MabThera</td><td>B62222</td><td>1.89 ± 0.11</td><td>2.91 ± 0.18</td><td>0.82 ± 0.12</td><td>45.58 ± 0.47</td><td>3.03 ± 0.17</td></tr><tr><td row... |
30ccba4cd7b20e4ced7a3bfe2cfbed28fb67694197e371cfdea0630a8d4d324a.png | complex | <table><tr><td>RIO—Psychosocial Measure</td><td colspan="2">Coefficient of Correlation</td></tr><tr><td>Temp. Fingers—Temp. Nose</td><td>0.450</td><td>**</td></tr><tr><td>—Interference General (BPI)</td><td>−0.390</td><td>*</td></tr><tr><td>—Interference Affective (BPI)</td><td>−0.51... | <table><tr><td>RIO—Psychosocial Measure</td><td colspan="2">Coefficient of Correlation</td></tr><tr><td>Temp. Fingers—Temp. Nose</td><td>0.450</td><td>**</td></tr><tr><td>—Interference General (BPI)</td><td>−0.390</td><td>*</td></tr><tr><td>—Interference Affective (BPI)</td><td>−0.517</td><td>*</td></tr><tr><td>—Interf... | <table><tr><td>Temp. Periorbital—Temp. Forehead</td><td>0.469</td><td>**</td></tr><tr><td>—Reappraisal (EQR)</td><td>−0.485</td><td>*</td></tr></table> |
27caa1b569164e8f6b8bedaf17abdecb0c4aba16c47899e7185a9ef4d034696a.png | simple | <table><tr><td>Experiment</td><td>Total reads</td><td>Aligned reads</td><td>Mean PCR duplicates (%)</td><td>Aligned reads on target</td><td>On-target rate (%)</td><td>Uniquely aligned reads<sup>a</sup></td><td>Uniquely aligned reads on target<sup>a</sup></td><td>On-target rate (%)<sup>a</sup></td><td>Mean coverage on t... | <table><tr><td>E</td><td>Total rea</td><td>Align</td><td>Mean PCR d</td><td>Aligned re</td><td>On-target r</td><td>Uniquel</td><td>Uniquely aligned reads</td><td>On-tar</td><td>Mean coverag</td></tr></table> | <table><tr><td>xperiment</td><td>ds</td><td>ed reads</td><td>uplicates (%)</td><td>ads on target</td><td>ate (%)</td><td>y aligned readsa</td><td> on targeta</td><td>get rate (%)a</td><td>e on target</td></tr><tr><td>dCATCH-SeqCATCH-Seq</td><td>853,358841,154</td><td>414,965802,931</td><td>47.42.8</td><td>382,625291,80... |
040d9be7f18437d3b1e9baeb56b6af288ece7e262d308b52da266c9fd725d777.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose (<i>μ</i>g/plate)</td><td colspan="4">Number of His<sup>+</sup> revertants colonies/plate</td></tr><tr><td>TA97a</td><td>TA98</td><td>TA100</td><td>TA102</td></tr><tr><td>Spontaneous</td><td> </td><td>140.0 ± 4.0</td><td>31.0 ± 3.6</td><td>128... | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose (μg/plate)</td><td colspan="2">Number of His+ revertants colonies/plate</td></tr><tr><td>TA97a</td><td>TA98</td></tr><tr><td>Spontaneous</td><td></td><td>140.0 ± 4.0</td><td>31.0 ± 3.6</td></tr><tr><td>Positive control (NaN3)</td><td>1.5</td><td>246.3 ± 16.0... | <table><tr><td colspan="2">Number of His+ revertants colonies/plate</td></tr><tr><td>TA100</td><td>TA102</td></tr><tr><td>128.7 ± 9.8</td><td>245.7 ± 23.3</td></tr><tr><td>352.0 ± 33.0</td><td>343.3 ± 33.3</td></tr><tr><td>191.7 ± 13.3</td><td>286.7 ± 26.3</td></tr><tr><td>172.3 ± 18.9</td><td>260.0 ± 24.1</td></tr><tr... |
74d4a05312fa850e84283a72ec46c51633cbabee7f8342fe6ebbd5b6754b8320.png | complex | <table><tr><td rowspan="2">Regression indices and explanatory variable</td><td>Dependent variable<sup>‡</sup></td></tr><tr><td>Eggs</td><td>Excreta</td></tr><tr><td>Intercept</td><td>-1.33<sup>**</sup> (0.45)</td><td>2.97<sup>**</sup> (0.23)</td></tr><tr><td>Regression coefficients</td><td></td><td></td></tr><tr>... | <table><tr><td rowspan="2">Regression indices and explanatory variable</td><td>Dependent variable‡</td><td></td></tr><tr><td>Eggs</td><td>Excreta</td></tr><tr><td>Intercept</td><td>-1.33** (0.45)</td><td>2.97** (0.23)</td></tr><tr><td>Regression coefficients</td><td></td><td></td></tr><tr><td>Area (Reference: Faridpur)... | <table><tr><td rowspan="2">Regression indices and explanatory variable</td><td>Dependent variable‡</td><td></td></tr><tr><td>Eggs</td><td>Excreta</td></tr><tr><td>Chandpur</td><td>-0.29* (0.15)</td><td>0.01 (0.08)</td></tr><tr><td>Satkhira</td><td>-0.28 (0.15)</td><td>0.02 (0.08)</td></tr><tr><td>Jessore</td><td>-0.22 ... |
8cf555500eb20f260f15e33d00350fc76b914c05c41e5932314ae15933bb22f7.png | simple | <table><tr><td>Species</td><td>Accession used for sequencing</td><td>Raw paired-end reads (DNA-, RNA-seq) (M)</td><td>Trimmed paired-end reads (DNA-, RNA-seq) (M)</td><td>Repetitive fraction (%) (SE)</td></tr><tr><td><i>H. agrestis</i></td><td>673199</td><td>38.3–40.4,40.0–44.0</td><td>28.6–29.5,36.3&... | <table><tr><td>Species</td><td>Accession used for sequencing</td><td>Raw paired-end reads (DNA-, RNA-seq) (M)</td><td>Trimmed paired-end reads (DNA-, RNA-seq) (M)</td><td>Repetitive fraction (%) (SE)</td></tr></table> | <table><tr><td>H. agrestis</td><td>673199</td><td>38.3–40.4,40.0–44.0</td><td>28.6–29.5,36.3–39.9</td><td>83.33 (0.02)</td></tr><tr><td>H. carnosus</td><td>649956</td><td>34.0–38.6,48.5–56.9</td><td>24.6–28.3,44.0–51.7</td><td>74.48 (0.04)</td></tr><tr><td>H. porteri</td><td>649918</td><td>42.4–63.5,35.8–49.7</td><td>3... |
e66ba8880463dd9006f424eab31ede3150fb45d8c451c9244c952257b8b54077.png | simple | <table><tr><td>Predictor</td><td>β coefficient</td><td>95% CI</td><td>Unadjusted <i>p</i> value<sup>a</sup></td></tr><tr><td>Age</td><td>0.08</td><td>0.02–0.15</td><td>0.009</td></tr><tr><td>Female</td><td>−0.22</td><td>−1.17 to 0.74</td><td>0.655</td></tr><tr><td>Marital status</td><td>0.02</td>... | <table><tr><td>Predictor</td><td>β coefficient</td><td>95% CI</td><td>Unadjusted p valuea</td></tr><tr><td>Age</td><td>0.08</td><td>0.02–0.15</td><td>0.009</td></tr><tr><td>Female</td><td>−0.22</td><td>−1.17 to 0.74</td><td>0.655</td></tr><tr><td>Marital status</td><td>0.02</td><td>−0.34 to 0.38</td><td>0.920</td></tr>... | <table><tr><td>Predictor</td><td>β coefficient</td><td>95% CI</td><td>Unadjusted p valuea</td></tr><tr><td>Pre-morbid employment</td><td>0.54</td><td>−0.16 to 1.24</td><td>0.131</td></tr><tr><td>Return to same employment</td><td>2.08</td><td>1.06–3.10</td><td><0.001</td></tr><tr><td>Time off from work</td><td>0.51</td>... |
84d417166909c96e33d16709eee8c679dd5ddeceb0ad9e652d3eec119df9cb14.png | complex | <table><tr><td colspan="2"> </td><td colspan="4">Women who selected specified method</td><td> </td><td colspan="4">Women who did not select specified method</td></tr><tr><td>Perception statement</td><td>Method</td><td>Strongly agree/agree n (%)</td><td>Strongly disagree/disagree n (%)</td><td>No opinion/do not know n (... | <table><tr><td colspan="2"></td><td colspan="4">Women who selected specified method</td><td></td><td colspan="4">Women who did not select specified method</td></tr><tr><td>Perception statement</td><td>Method</td><td>Strongly agree/agree n (%)</td><td>Strongly disagree/disagree n (%)</td><td>No opinion/do not know n (%)... | <table><tr><td>Regular menstrual bleeding</td><td>Ring</td><td>4064 (75.5)</td><td>86 (1.6)</td><td>1233 (22.9)</td><td>157</td><td>Ring</td><td>6003 (47.9)</td><td>346 (2.8)</td><td>6180 (49.3)</td><td>718</td></tr><tr><td rowspan="3">Protects against cancer</td><td>Pill</td><td>2686 (28.9)</td><td>1542 (16.6)</td><td... |
f3adf4dde63853b1ab85973741b2f424ccf62ab57974289d8820c16807e5625c.png | simple | <table><tr><td>Secure environment (SE) employment type</td><td>Less than 10 years</td><td>11 – 20 years</td><td>21 – 30 years</td><td>Over 30 years</td><td>TOTAL</td></tr><tr><td>GPs predominantly employed in SE</td><td>3</td><td>8</td><td>8</td><td>4</td><td>23</td></tr><tr><td>GP principals</td><td>1</td>... | <table><tr><td>Secure environment (SE) employment type</td><td>Less than 10 years</td><td>11 – 20 years</td><td>21 – 30 years</td><td>Over 30 years</td><td>TOTAL</td></tr><tr><td>GPs predominantly employed in SE</td><td>3</td><td>8</td><td>8</td><td>4</td><td>23</td></tr><tr><td>GP pr</td><td>1</td><td></td><td>4</td><... | <table><tr><td>Secure environment (SE) employment type</td><td>Less than 10 years</td><td>11 – 20 years</td><td>21 – 30 years</td><td>Over 30 years</td><td>TOTAL</td></tr><tr><td>incipals</td><td></td><td>2</td><td></td><td>2</td><td></td></tr><tr><td>TOTAL</td><td>4</td><td>10</td><td>12</td><td>6</td><td>32</td></tr>... |
3a26a239d2375f48d08d773e33a10816e08b0b779ab52eae6009279f89729d78.png | complex | <table><tr><td></td><td>National sponsors</td><td>International sponsors</td></tr><tr><td>When to report adverse events</td><td>Frequency</td><td>Frequency</td></tr><tr><td colspan="3">Serious adverse events</td></tr><tr><td> No later than 1 hour</td><td>0</td><td>0</td></tr><tr><td> No later than 24 hours</td><td>0</t... | <table><tr><td></td><td>National sponsors</td><td>International sponsors</td></tr><tr><td>When to report adverse events</td><td>Frequency</td><td>Frequency</td></tr><tr><td colspan="3">Serious adverse events</td></tr><tr><td>No later than 1 hour</td><td>0</td><td>0</td></tr><tr><td>No later than 24 hours</td><td>0</td>... | <table><tr><td>ter than 15 days</td><td>0</td><td></td></tr><tr><td>Others</td><td>0</td><td>6</td></tr><tr><td>Did not specify</td><td>30</td><td>48</td></tr><tr><td>Total</td><td>31</td><td>71</td></tr></table> |
815f91c399472b63e57e568f3ede972e43cd390dab5ff8704955599f3d8964fa.png | simple | <table><tr><td> </td><td>PCS-36</td><td>MCS-36</td><td>DHI</td><td>HADS</td></tr><tr><td>PCS-36</td><td>1</td><td> </td><td> </td><td> </td></tr><tr><td>MCS-36</td><td>0.22**</td><td>1</td><td> </td><td> </td></tr><tr><td>DHI</td><td>−0.64***</td><td>−0.57***</td><td>1</td><td> </td></tr><tr><td>HADS</td><t... | <table><tr><td></td><td>PCS-36</td><td>MCS-36</td><td>DHI</td><td>HADS</td></tr><tr><td>PCS-36</td><td>1</td><td></td><td></td><td></td></tr><tr><td>MCS-36</td><td>0.22**</td><td>1</td><td></td><td></td></tr><tr><td>DHI</td><td>−0.64***</td><td>−0.57***</td><td>1</td><td></td></tr><tr><td>HADS</td><td>−0.32***</td><td>... | <table><tr><td>Va</td><td>4***</td><td>.64*</td><td>65**</td><td>8**</td></tr><tr><td>Age</td><td>−0.03</td><td>0.01</td><td>0.004</td><td>−0.02</td></tr><tr><td>Gender</td><td>0.03</td><td>0.13</td><td>−0.12</td><td>−0.03</td></tr></table> |
0e7bdea765baf1b8c7a4bdd07f8c7f113835c14bffa21e441837ab9452e7f582.png | complex | <table><tr><td></td><td>Mean (SD) or %</td></tr><tr><td>Age, mean (SD)</td><td>63.5 (13.8)</td></tr><tr><td> 18–45, %</td><td>11.5%</td></tr><tr><td> 46–70, %</td><td>51.5%</td></tr><tr><td>≥ 71, %</td><td>37.0%</td></tr><tr><td>Male, %</td><td>35.3%</td></tr><tr><td colspan="2">Marital status, %</td>... | <table><tr><td></td><td>Mean (SD) or %</td></tr><tr><td>Age, mean (SD)</td><td>63.5 (13.8)</td></tr><tr><td>18–45, %</td><td>11.5%</td></tr><tr><td>46–70, %</td><td>51.5%</td></tr><tr><td>≥ 71, %</td><td>37.0%</td></tr></table> | <table><tr><td>Male, %</td><td>35.3%</td></tr><tr><td colspan="2">Marital status, %</td></tr><tr><td>Married</td><td>70.7%</td></tr><tr><td>Single</td><td>3.7%</td></tr><tr><td>Widowed/Separated/divorced</td><td>25.6%</td></tr><tr><td>Living alone, %</td><td>15.2%</td></tr><tr><td colspan="2">Level of education, %</td>... |
fbc027376222fccd528adfc39bb9198a00aa41c99d46c2fdf2ec919fe20622df.png | complex | <table><tr><td>Group</td><td>HC (n = 21)</td><td>Mild AD (n = 17)</td><td>AD-MCI (n = 23)</td><td><i>p</i></td></tr><tr><td>Female</td><td>13</td><td>7</td><td>11</td><td rowspan="2">0.42</td></tr><tr><td>Male</td><td>8</td><td>10</td><td>12</td></tr><tr><td>Age</td><td>66.4 ± 7.5</td><td>68.9 ± 8.1</td><td>6... | <table><tr><td>Group</td><td>HC (n = 21)</td><td>Mild AD (n = 17)</td><td>AD-MCI (n = 23)</td><td>p</td></tr><tr><td>Female</td><td>13</td><td>7</td><td>11</td><td rowspan="2">0.42</td></tr><tr><td>Male</td><td>8</td><td>10</td><td>12</td></tr></table> | <table><tr><td>Group</td><td>HC (n = 21)</td><td>Mild AD (n = 17)</td><td>AD-MCI (n = 23)</td><td>p</td></tr><tr><td>Age</td><td>66.4 ± 7.5</td><td>68.9 ± 8.1</td><td>67.6 ± 5.4</td><td>0.53</td></tr><tr><td>MMSE score</td><td>29.4 ± 0.8</td><td>22.1 ± 4.3</td><td>26.8 ± 2.0</td><td><0.01</td></tr><tr><td>Delayed recal... |
4f5f502a5db3457b4c54f13e4c9cd7f76e409262e57da5897a3fb3000c58d171.png | complex | <table><tr><td colspan="2">Clinical features</td><td colspan="2">Pathoanatomy</td><td colspan="2">Treatment based approach</td><td colspan="2">Screening/Prediction tool</td><td colspan="2">Pain mechanisms</td></tr><tr><td>Barker 1990 [79]</td><td>2</td><td>Bernard and Kirkaldy Willis 1987 [41]</td><td>2</td><td>Albert ... | <table><tr><td colspan="2">Clinical features</td><td colspan="2">Pathoanatomy</td><td colspan="2">Treatment based approach</td><td colspan="2">Screening/Prediction tool</td><td colspan="2">Pain mechanisms</td></tr><tr><td></td><td></td><td>Bernard </td><td>2</td><td></td><td>4</td><td></td><td>3</td><td>Schafer e</td><... | <table><tr><td>Barker 1990 [79]</td><td>2</td><td>and Kirkaldy Willis 1987 [41]</td><td></td><td>Albert et al. 2012 [61]</td><td></td><td>Fritz et al. 2007 [64]</td><td></td><td>t al. 2009 [65]</td><td></td></tr><tr><td>Ben Debba et al. 2000 [36]</td><td>3.5</td><td>Cassisi et al. 1993 [38]</td><td>3</td><td>Hall et al... |
06cc524159589d1a0e0ff7fc174c0e67d71a8445c8555edee4ca38071a123b37.png | simple | <table><tr><td>Gene</td><td>Primer</td><td>Sequence</td><td>Amplicon</td><td>Tm (°C)</td></tr><tr><td>GK</td><td>Forward</td><td>5′-CATATGTGCTCCGCAGGACTA-3′</td><td>105 bp</td><td>61.7</td></tr><tr><td></td><td>Reverse</td><td>5′-CTTGTACACGGAGCCATCCA-3′</td><td></td><td></td></tr><tr><td>HK... | <table><tr><td>Gene</td><td>Primer</td><td>Sequence</td><td>Amplicon</td><td>Tm (°C)</td></tr><tr><td>GK</td><td>Forward</td><td>5′-CATATGTGCTCCGCAGGACTA-3′</td><td>105 bp</td><td>61.7</td></tr><tr><td></td><td>Reverse</td><td>5′-CTTGTACACGGAGCCATCCA-3′</td><td></td><td></td></tr><tr><td>HK</td><td>Forward</td><td>5′-A... | <table><tr><td></td><td>erse</td><td>CCCGGATGTG-3′</td><td></td><td></td></tr><tr><td>F16BP</td><td>Forward</td><td>5′-CGTCCTATGCTACCTGTGTCCTT-3′</td><td>73 bp</td><td>81</td></tr><tr><td></td><td>Reverse</td><td>5′-CCCCTCTTCTCGGGCTCTATTAT-3′</td><td></td><td></td></tr><tr><td>PEPCK</td><td>Forward</td><td>5′-GCAACTTCT... |
5360415ac31cebad1ee4406f62f2e344dfa4598bd798676128eaf39f8df1e1db.png | simple | <table><tr><td>Sampling time (expression change)</td><td>Ischemia-related</td><td>PACAP-related</td><td>PACAP in ischemia-related</td><td>Common: ischemia-related and PACAP in ischemia-related</td><td>Common: PACAP-related and PACAP in ischemia-related</td></tr><tr><td>6 h (upregulated)</td><td>1,237</td><td>435</td><t... | <table><tr><td>Sampling time (expression change)</td><td>Ischemia-related</td><td>PACAP-related</td><td>PACAP in ischemia-related</td><td>Common: ischemia-related and PACAP in ischemia-related</td><td>Common: PACAP-related and PACAP in ischemia-related</td></tr></table> | <table><tr><td>6 h (upregulated)</td><td>1,237</td><td>435</td><td>839</td><td>171</td><td>43</td></tr><tr><td>6 h (downregulated)</td><td>622</td><td>743</td><td>498</td><td>31</td><td>24</td></tr><tr><td>24 h (upregulated)</td><td>2,759</td><td>263</td><td>831</td><td>49</td><td>30</td></tr><tr><td>24 h (downregulate... |
e91c87bfdbb0b40ba0af9173809a700f9e249ea8640b6f259aea55d6d6192548.png | simple | <table><tr><td></td><td>JIA-associated NIU (n = 14)</td><td>Pure NIU (n = 11)</td><td>Total</td></tr><tr><td>Bilateral (pts)</td><td>12/14</td><td>11/11</td><td>23/25</td></tr><tr><td>Total eyes with NIU</td><td>24</td><td>22</td><td>46</td></tr><tr><td>Location:</td><td></td><td></td><td></td></tr><tr><td>Anterior/Pos... | <table><tr><td></td><td>JIA-associated NIU (n = 14)</td><td>Pure NIU (n = 11)</td><td>Total</td></tr><tr><td>Bilateral (pts)</td><td>12/14</td><td>11/11</td><td>23/25</td></tr></table> | <table><tr><td>Total eyes with NIU</td><td>24</td><td>22</td><td>46</td></tr><tr><td>Location:</td><td></td><td></td><td></td></tr><tr><td>Anterior/Posterior/Panuveitis</td><td>12/6/2</td><td>2/4/2</td><td>16/7/2</td></tr></table> |
e88c1d26806fba26d5897ac367de5d965f0c3dbea4108d874b4abd6214aa7170.png | complex | <table><tr><td colspan="2">Nutrients</td><td>Number of Foods</td><td>Energy</td><td>Saturated Fatty Acids</td><td>Cholesterol</td><td>Na</td><td>Total Sugar</td><td>Added Sugars</td><td>Ca</td><td>Vitamin D</td><td>K</td><td>Fiber</td></tr><tr><td colspan="2">Units of Nutrient Intake</td><td></td><td>Kcal</td><td>g</td... | <table><tr><td colspan="2">Nutrients</td><td>Number of Foods</td><td>Energy</td><td>Saturated Fatty Acids</td><td>Cholesterol</td><td>Na</td><td>Total Sugar</td><td>Added Sugars</td><td>Ca</td><td>Vitamin D</td><td>K</td><td>Fiber</td></tr><tr><td colspan="2">Units of Nutrient Intake</td><td></td><td>Kcal</td><td>g</td... | <table><tr><td colspan="2">Nutrients</td><td>Number of Foods</td><td>Energy</td><td>Saturated Fatty Acids</td><td>Cholesterol</td><td>Na</td><td>Total Sugar</td><td>Added Sugars</td><td>Ca</td><td>Vitamin D</td><td>K</td><td>Fiber</td></tr><tr><td colspan="2">Units of Nutrient Intake</td><td></td><td>Kcal</td><td>g</td... |
b9969297e70bffd261bc626bbb75d78e852a2d4b3b4af84755c9cd3ad62a08a6.png | simple | <table><tr><td>Reference</td><td>Strains</td><td>Plasmids</td><td>Time (h)</td><td>IPTG-conc. (mM)</td><td>RPM (1/min)</td><td>Temperature (°C)</td><td>δ-ALA-conc. (mM)</td><td>Thiamin-conc. (mM)</td></tr><tr><td>[46]</td><td>BL21(DE3)</td><td>pET28a</td><td>2</td><td>0.2</td><td></td><td>25</td><td></td><td>... | <table><tr><td>Reference</td><td>Strains</td><td>Plasmids</td><td>Time (h)</td><td>IPTG-conc. (mM)</td><td>RPM (1/min)</td><td>Temperature (°C)</td><td>δ-ALA-conc. (mM)</td><td>Thiamin-conc. (mM)</td></tr><tr><td>[46]</td><td>BL21(DE3)</td><td>pET28a</td><td>2</td><td>0.2</td><td></td><td>25</td><td></td><td></td></tr>... | <table><tr><td>Reference</td><td>Strains</td><td>Plasmids</td><td>Time (h)</td><td>IPTG-conc. (mM)</td><td>RPM (1/min)</td><td>Temperature (°C)</td><td>δ-ALA-conc. (mM)</td><td>Thiamin-conc. (mM)</td></tr><tr><td></td><td></td><td></td><td>10</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>[49]</td><td>JM... |
647a2cb4d3987aab4b52553a3331aa9ab95cf2ceb603dbd87a5838b91f08bbf3.png | complex | <table><tr><td></td><td>Current</td><td colspan="2">Projected</td></tr><tr><td></td><td></td><td>Only MVA<sup>3</sup></td><td>MVA/Misoprostol<sup>4</sup></td></tr><tr><td colspan="4">Procedure type distribution for first trimester, legal, induced abortion</td></tr><tr><td>MVA ($17)</td><td></td><td>100 %</td><td>70 %</... | <table><tr><td></td><td>Current</td></tr><tr><td></td><td></td></tr><tr><td colspan="2">Procedure type distribution for first trimester, legal, induced abortion</td></tr><tr><td>MVA ($17)</td><td></td></tr><tr><td>Misoprostol-alone ($10)</td><td></td></tr><tr><td>Total annual cost</td><td>$314,008[$287,406 - $502,522]<... | <table><tr><td colspan="2">Projected</td></tr><tr><td>Only MVA3</td><td>MVA/Misoprostol4</td></tr><tr><td colspan="2">Procedure type distribution for first trimester, legal, induced abortion</td></tr><tr><td>100 %</td><td>70 %</td></tr><tr><td>-</td><td>30 %</td></tr><tr><td>$250,332</td><td>$219,408</td></tr><tr><td>2... |
b6e71e1fec0a51029b7a44ca7d1ad214d381901798e31cc35be8259166fa77e8.png | complex | <table><tr><td>Clinical parameter</td><td>SLE patients</td><td>Healthy Controls</td><td><i>P</i> value</td></tr><tr><td>Patients (number)</td><td>52</td><td>52</td><td>–</td></tr><tr><td>Age (years)</td><td>31 (12–52)</td><td>32 (20–56)</td><td>0.438</td></tr><tr><td>Female:Male ratio</td><td>46:6</td... | <table><tr><td>Clinical parameter</td><td>SLE patients</td><td>Healthy Controls</td><td>P value</td></tr><tr><td>Patients (number)</td><td>52</td><td>52</td><td>–</td></tr><tr><td>Age (years)</td><td>31 (12–52)</td><td>32 (20–56)</td><td>0.438</td></tr><tr><td>Female:Male ratio</td><td>46:6</td><td>45:7</td><td>0.767</... | <table><tr><td>HDL (mmol/L)</td><td>1.06 (0.35–2.01)</td><td>1.44 (1.05–2.15)</td><td><0.001</td></tr><tr><td>LDL (mmol/L)</td><td>2.50 (0.89–7.06)</td><td>2.53 (1.44–3.78)</td><td>0.062</td></tr><tr><td>APOA1 (g/L)</td><td>1.14 (0.57–2.01)</td><td>1.45 (1.08–1.89)</td><td><0.001</td></tr><tr><td>APOB (g/L)</td><td>0.9... |
a07c7da399aafbae824a0562b782635416e68af64f9415f68c22c54e9ffc6bba.png | simple | <table><tr><td><i>Model</i></td><td>Test set</td><td>SN<i>(%)</i></td><td>PE<i>(%)</i></td><td>ACC<i>(%)</i></td><td>MCC<i>(%)</i></td><td>AUC<i>(%)</i></td></tr><tr><td>Ourmethod</td><td>1</td><td>91.66</td><td>92.40</td><td>92.00</td><td>85.28</td><td>97.15</td></tr><tr><td></td><td>2</td><td>90.49</td><td>92.01</td>... | <table><tr><td>Model</td><td>Test set</td><td>SN(%)</td><td>PE(%)</td><td>ACC(%)</td><td>MCC(%)</td><td>AUC(%)</td></tr><tr><td>Ourmethod</td><td>1</td><td>91.66</td><td>92.40</td><td>92.00</td><td>85.28</td><td>97.15</td></tr><tr><td></td><td>2</td><td>90.49</td><td>92.01</td><td>91.11</td><td>83.79</td><td>96.91</td>... | <table><tr><td>Test set</td><td>SN(%)</td><td>PE(%)</td><td>ACC(%)</td><td>MCC(%)</td><td>AUC(%)</td></tr><tr><td></td><td>± 0.90</td><td>81.86 ± 0.99</td><td> ± 0.47</td><td>A</td><td>/A</td></tr><tr><td>Cod4</td><td>81.03 ± 1.74</td><td>90.24 ± 1.34</td><td>86.15 ± 1.17</td><td>N/A</td><td>N/A</td></tr></table> |
8221051755f64d9ba35697241eca13022fcc1bcf7e9efeb14bcaf5c7c327496d.png | simple | <table><tr><td>Compound</td><td>Inhibitor concentration (mg/L)</td></tr><tr><td>Furfural</td><td>19.65 ± 0.81</td></tr><tr><td>Hydroxymethylfurfural (HMF)</td><td>3.89 ± 0.25</td></tr><tr><td>Glucuronic acid</td><td>ND</td></tr><tr><td><i>p</i>-coumaric acid</td><td>ND</td></tr><tr><td>Syringic acid</td><td>N... | <table><tr><td>Compound</td><td>Inhibitor concentration (mg/L)</td></tr><tr><td>Furfural</td><td>19.65 ± 0.81</td></tr><tr><td>Hydroxymethylfurfural (HMF)</td><td>3.89 ± 0.25</td></tr></table> | <table><tr><td>Compound</td><td>Inhibitor concentration (mg/L)</td></tr><tr><td>Glucuronic acid</td><td>ND</td></tr><tr><td>p-coumaric acid</td><td>ND</td></tr><tr><td>Syringic acid</td><td>ND</td></tr><tr><td>Ferulic acid</td><td>ND</td></tr></table> |
2335d20dde27a54e190453202bf4c6adc3a78b1a16bee9add7c317b0f8b712e3.png | complex | <table><tr><td colspan="2">Targeted neurotransmitter</td><td>Agents under investigation</td><td>Status</td><td>Ref.</td></tr><tr><td colspan="2">Acetylcholine</td><td>LatrepirdineHuperzine A</td><td>(III)</td><td>76</td></tr><tr><td rowspan="2" colspan="2">GABA</td><td>SGS742</td><td>(II)*</td><td></td></tr><tr><td>ADS... | <table><tr><td colspan="2">Targeted neurotransmitter</td><td>Agents under investigation</td><td>Status</td><td>Ref.</td></tr><tr><td colspan="2">Acetylcholine</td><td>LatrepirdineHuperzine A</td><td>(III)</td><td>76</td></tr><tr><td rowspan="2" colspan="2">GABA</td><td>SGS742</td><td>(II)*</td><td></td></tr><tr><td>ADS... | <table><tr><td colspan="2">Targeted neurotransmitter</td><td>Agents under investigation</td><td>Status</td></tr><tr><td colspan="2">Adenosine</td><td>SCH58261</td><td>–</td></tr></table> |
d07a72584a090448d5505e46d0b7e5be67cde7cade21b0b1282b7c3ca077e195.png | complex | <table><tr><td colspan="2"><i>Factors</i></td><td><i>Outcome (n = 10)</i></td></tr><tr><td rowspan="2"><i>Boiling/treatment of drinking water:</i></td><td>Yes</td><td>0</td></tr><tr><td>No</td><td>10 (100%)</td></tr><tr><td rowspan="2"><i>Regular hand washing after toilet use</i>:</td><td>Yes</td><td>3 (30%)</td></tr><... | <table><tr><td colspan="2">Factors</td><td>Outcome (n = 10)</td></tr><tr><td rowspan="2">Boiling/treatment of drinking water:</td><td>Yes</td><td>0</td></tr><tr><td>No</td><td>10 (100%)</td></tr><tr><td rowspan="2">Regular hand washing after toilet use:</td><td>Yes</td><td>3 (30%)</td></tr><tr><td>No</td><td>7 (70%)</t... | <table><tr><td rowspan="2">Consumption of pork:</td><td>Yes</td><td>10 (100%)</td></tr><tr><td>No</td><td>0</td></tr><tr><td rowspan="2">Roasting and eating pork while handling raw pork:</td><td>Yes</td><td>4 (40%)</td></tr><tr><td>No</td><td>6 (60%)</td></tr><tr><td rowspan="3">Method of pork processing for consumptio... |
de6b84b3585655ef96da0dbc4375404cdc5e946036fa5ae169201b3b371650b6.png | simple | <table><tr><td>Abiotic stress</td><td></td><td>Reference</td></tr><tr><td>Drought</td><td>CZP 9802; 863B, PRLT 2/89-33ICMP 83720, ICMV 9413, and ICMV 94472</td><td>Yadav, 2004; Dwivedi et al., 2010</td></tr><tr><td>Heat</td><td>H77/833-2, H77/29-2, CVJ 2-5-3-1-3, 77/371XBSECT CP1, 96AC-93, 1305, 77/371, Togo II, 99HS-1... | <table><tr><td>Abiotic stress</td><td></td><td>Reference</td></tr><tr><td>Drought</td><td>CZP 9802; 863B, PRLT 2/89-33ICMP 83720, ICMV 9413, and ICMV 94472</td><td>Yadav, 2004; Dwivedi et al., 2010</td></tr><tr><td>Heat</td><td>H77/833-2, H77/29-2, CVJ 2-5-3-1-3, 77/371XBSECT CP1, 96AC-93, 1305, 77/371, Togo II, 99HS-1... | <table><tr><td>Downy mildew (Sclerospora graminicola)</td><td>ICMPE #13-6-30, 134-6-9, 134-6-34, 13-6-27, 37, and 71;ICML #1, 2, 3, 4, 5, 6, 7, 8, 9, 10; ICMA #91333, 91444, and 91555; ICMA 92666 and ICMB 92666 (resistant to ergot, smut, and downy mildew)</td><td>Thakur et al., 1982; Willingale et al., 1986; Thakur and... |
64cc32e7112502f5d59e99c0bcd202b3bcc4b41f5df4d0ffbb541fc8e1e9a919.png | complex | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="2">Attempted suicide</td><td colspan="2">Completed suicide</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>No. (%)</td><td>Annual incidence rate</td><td>No. (%)</td><td>Annual incidence rate</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>29... | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="2">Attempted suicide</td><td colspan="2">Completed suicide</td><td rowspan="2">p-value</td></tr><tr><td>No. (%)</td><td>Annual incidence rate</td><td>No. (%)</td><td>Annual incidence rate</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>2939(96.9... | <table><tr><td rowspan="7">City of Residence</td><td>Ilam</td><td>2615(97.9)</td><td>87.38</td><td>57(2.1)</td><td>1.9</td><td rowspan="7">0.087</td></tr><tr><td>Ayvan</td><td>942(98)</td><td>134.46</td><td>19(2)</td><td>2.71</td></tr><tr><td>Dareh-shahr</td><td>1289(96.6)</td><td>154.56</td><td>45(3.4)</td><td>5.4</td... |
73ba9d726e55ded0c90da424fa4c9f2c6e905da161eac492c3ba2db62390c4eb.png | simple | <table><tr><td> </td><td> </td><td> </td><td>Unexposed</td><td>Exposed*</td><td>Surgery targeted by study</td></tr><tr><td>Time window</td><td>Tissue/structure group</td><td>Subject</td><td>No. (%)</td><td>No. (%)</td><td>OR (95% CI)</td></tr><tr><td>Time window 4</td><td>Lymph nodes</td><td><i>Case</i></td><td>165 (98... | <table><tr><td></td><td></td><td></td><td>Unexposed</td><td>Exposed*</td><td>Surgery targeted by study</td></tr><tr><td>Time window</td><td>Tissue/structure group</td><td>Subject</td><td>No. (%)</td><td>No. (%)</td><td>OR (95% CI)</td></tr><tr><td>Time window 4</td><td>Lymph nodes</td><td>Case</td><td>165 (98.8)</td><t... | <table><tr><td></td><td></td><td>UMC</td><td>2,223 (100.0)</td><td>1 (0.0)</td><td>36.35 (1.86–711.57)</td></tr><tr><td></td><td>Lymph nodes</td><td>Case</td><td>166 (99.4)</td><td>1 (0.6)</td><td></td></tr><tr><td></td><td></td><td>MC</td><td>831 (99.5)</td><td>4 (0.5)</td><td>1.25 (0.14–11.26)</td></tr><tr><td></td><... |
0a3d6e78b8b9bd57ac14f7b894177f6e679c478fe32d4b197023ed41f3139c77.png | simple | <table><tr><td>Tract</td><td>Wave-1</td><td>Wave-2</td><td><i>P</i>-value</td><td><i>N</i></td><td>% ΔFA/year</td><td><i>M</i></td></tr><tr><td>ACF</td><td>0.437 ± 0.033</td><td>0.420 ± 0.028</td><td><0.001</td><td>74</td><td>−1.50</td><td>1</td></tr><tr><td>LH CST</td><td>0.434 ± 0.025</td... | <table><tr><td>Tr</td><td>Wav</td><td>W</td><td></td><td></td><td>% </td><td></td></tr></table> | <table><tr><td>act</td><td>e-1</td><td>ave-2</td><td>P-value</td><td>N</td><td>ΔFA/year</td><td>M</td></tr><tr><td>ACF</td><td>0.437 ± 0.033</td><td>0.420 ± 0.028</td><td><0.001</td><td>74</td><td>−1.50</td><td>1</td></tr><tr><td>LH CST</td><td>0.434 ± 0.025</td><td>0.439 ± 0.023</td><td>0.014</td><td>76</td><td>0.49</... |
0e05883e91bcc6c4b0dffdefc66318a1e38681087300f6a3e3f3a0441c69c964.png | simple | <table><tr><td>Variable</td><td>Hazard ratio</td><td>95% CI</td><td><i>P</i>value</td></tr><tr><td>Age</td><td>0.987</td><td>0.938-1.039</td><td>0.611</td></tr><tr><td>Interval time (mos.) from AP</td><td>0.564</td><td>0.147-2.158</td><td>0.403</td></tr><tr><td>Multi-agent failure therapy</td><td>3.177</td><td>1.277-7.... | <table><tr><td>Variable</td><td>Hazard ratio</td><td>95% CI</td><td>Pvalue</td></tr><tr><td>Age</td><td>0.987</td><td>0.938-1.039</td><td>0.611</td></tr><tr><td>Interv</td><td>0.5</td><td>0.147-2.</td><td>0.4</td></tr></table> | <table><tr><td>al time (mos.) from AP</td><td>64</td><td>158</td><td>03</td></tr><tr><td>Multi-agent failure therapy</td><td>3.177</td><td>1.277-7.908</td><td>0.013</td></tr><tr><td>Liver metastasis</td><td>1.897</td><td>0.787-4.573</td><td>0.154</td></tr><tr><td>Kidney metastasis</td><td>2.654</td><td>1.125-6.261</td>... |
d37b4933e97379222accfd63d3bad8d08fc8b8d85ac33eb75d12f72f5a341426.png | complex | <table><tr><td>Sorghum containing diets</td><td>Dose</td><td>TVFA(mM)</td><td>Acetate(mM)</td><td>Propionate(mM)</td><td>Butyrate(mM)</td></tr><tr><td rowspan="4">HFD (80R : 20C)</td><td>0</td><td>51.5</td><td>34.2</td><td>11.1</td><td>6.3</td></tr><tr><td>5</td><td>62.7</td><td>39.8</td><td>16.2</td><td>6.7</td></tr><... | <table><tr><td>Sorghum containing diets</td><td>Dose</td><td>TVFA(mM)</td><td>Acetate(mM)</td><td>Propionate(mM)</td><td>Butyrate(mM)</td></tr><tr><td rowspan="4">HFD (80R : 20C)</td><td>0</td><td>51.5</td><td>34.2</td><td>11.1</td><td>6.3</td></tr><tr><td>5</td><td>62.7</td><td>39.8</td><td>16.2</td><td>6.7</td></tr><... | <table><tr><td rowspan="4">LFD (20R : 80C)</td><td>0</td><td>64.5</td><td>43.8</td><td>12.7</td><td>7.9</td></tr><tr><td>5</td><td>70.3</td><td>43.2</td><td>19.5</td><td>7.6</td></tr><tr><td>10</td><td>71.0</td><td>42.4</td><td>21.5</td><td>7.1</td></tr><tr><td>15</td><td>72.7</td><td>41.9</td><td>23.0</td><td>7.7</td>... |
cb54cd6ae2b5f8547cc287935d641231cafb7fdb78b8346b2487fecfb7889a1f.png | simple | <table><tr><td></td><td>N</td><td>(%)</td></tr><tr><td>Uterine atony</td><td>179</td><td>(55)</td></tr><tr><td>Placenta abnormalities;</td><td>173</td><td>(53)</td></tr><tr><td> Retained</td><td>54</td><td>(17)</td></tr><tr><td> Previa</td><td>37</td><td>(11)</td></tr><tr><td> Abnormally invasive placenta</td><td>32</t... | <table><tr><td></td><td>N</td><td>(%)</td></tr><tr><td>Uterine atony</td><td>179</td><td>(55)</td></tr><tr><td>Placenta abnormalities;</td><td>173</td><td>(53)</td></tr><tr><td></td><td></td><td>(1</td></tr></table> | <table><tr><td></td><td>N</td><td>(%)</td></tr><tr><td>Retained</td><td>54</td><td>7)</td></tr><tr><td>Previa</td><td>37</td><td>(11)</td></tr><tr><td>Abnormally invasive placenta</td><td>32</td><td>(10)</td></tr><tr><td>Remnant</td><td>30</td><td>(9)</td></tr><tr><td>Abruption</td><td>20</td><td>(6)</td></tr><tr><td>L... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.